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CHAPTER 1 
General introduction 
The first patient to be described suffering from a myopathy and 
structural mitochondrial abnormalities experienced severe heat intolerance, 
polyphagia, polydipsia and mild generalized fatigue with weakness on 
exertion. These symptoms could be satisfactorily explained by a defective 
coupling of oxidation and phosphorylation (Luft et al., 1962). Since this 
historic observation a steadily increasing number of patients have been 
described with structural abnormalities in the mitochondria of skeletal 
muscle. Although a number of the disorders observed in these patients 
appear to be confined to skeletal muscle, sometimes there are indications of 
a more widespread multisystem disease which may affect a variety of 
organs, including the brain, retina, liver, kidneys, peripheral nervous system 
and heart (for recent reviews see: Sengers et al., 1984; Morgan-Hughes, 
1986; Engel, 1988; Lombes et al, 1989). 
Clinical background 
Despite the considerable overlap in the clinical presentation of the 
mitochondrial (encephalo)myopathies, a few distinctive syndromes can be 
recognized. In the group of disorders affecting skeletal muscle predominant-
ly or exclusively, exercise intolerance is a frequently occurring symptom 
(Petty et al., 1986). The onset is usually between birth and the age of 10 
years (Sengers et al., 1984). Directly after birth mitochondrial myopathy 
should be considered in floppy infants and in babies with perinatal problems 
unexplained by asphyxia, intoxication or infection (Trijbels et al., 1988). 
Older patients may be hampered lifelong by steady or slowly progressive 
fatigability which is out of proportion to the degree of muscle weakness. 
The clinical presentation is quite variable. In the "Nijmegen" syndrome 
originally described by Sengers et al. (1975), mitochondrial myopathy of 
skeletal muscle is combined with hypertrophic cardiomyopathy, congenital 
cataract and exercise related lactic acidosis. This syndrome presents shortly 
after birth, but its course is quite unpredictable. In benign infantile mito-
chondrial myopathy associated with cytochrome oxidase deficiency, the 
symptoms subside within the first years of life, whereas fatal infantile 
mitochondrial myopathy, sometimes associated with renal dysfunction (De 
Toni-Fanconi-Debre syndrome), leads to death within one year of birth 
(DiMauro et al., 1988). Another frequently occurring symptom within the 
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group with (predominant) involvement of skeletal muscle is Chronic Pro-
gressive External Ophthalmoplegia (CPEO). CPEO can occur either alone or 
accompanied by limb muscle weakness, dysphagia or dysarthria (Lombes et 
al., 1989). 
In the group with multisystemic disease it is mainly the involvement of 
the brain which provides typical clinical features. In the Kearns-Sayre 
syndrome, CPEO may be combined with cerebellar ataxia, heart block, 
retinitis pigmentosa, mental changes and several other abnormalities (Kearns 
& Sayre, 1958; Bolthauser et al., 1977). The onset is before the age of 15 
years and the course is dependent on the organs involved. Other examples 
of mitochondrial encephalomyopathies include MERRF (Myoclonus Epilepsy 
and Ragged Red Fibres; Fukuhara et ai, 1980), MELAS (Mitochondrial 
Myopathy, Encephalopathy, Lactic Acidosis and Stroke-like episodes; 
Pavlakis et al., 1984), SNE (Subacute Necrotizing Encephalomyelopathy or 
Leigh syndrome; Egger et al., 1984) and PNDC (Progressive Neuronal 
Degeneration of Childhood or Alpers syndrome; Egger et al., 1987). These 
syndromes are usually fatal within a few years of onset. 
It should be emphasized that many transitional forms of mitochondrial 
(encephalo)myopathies exist and that the above-mentioned subdivision of 
clinical appearances may be too strict (Peiffer et al., 1988). 
Histopathological observations 
Muscular biopsy from a patient suffering from a mitochondrial myopa-
thy may appear unaltered in routine histopathological examination. Staining 
techniques for oxidative enzymes such as succinic dehydrogenase and 
NADH dehydrogenase may reveal fibres with an increased activity beneath 
the sarcolemma. Occasionally these fibres appear in the modified Gomori 
trichrome stain as 'ragged red' fibres, so-called because of the mottled and 
irregular appearance of the border zone. Ragged red fibres are sometimes 
surrounded by numerous capillaries (Stadhouders & Sengers, 1987). When 
inspecting a ragged red fibre in longitudinal section it is often noted that the 
pathology does not affect the whole fibre, but is restricted to a certain 
segment of an otherwise normal looking fibre. Ragged red fibres are 
generally type I fibres. 
On electron microscopic examination, excessive accumulation of 
glycogen particles and triglyceride droplets is one of the common features in 
mitochondrial myopathies. Generally, the fine structural appearance of the 
majority of the mitochondria is disturbed. Alterations in the distribution and 
the amount of mitochondria are common findings. The concept of a division 
of mitochondrial myopathies in 'pleoconial' and 'megaconial' types in which 
either the number or the size of the mitochondria is increased, as originally 
proposed by Shy and coworkers (Shy & Gonatas, 1964; Shy et al., 1966), is 
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not longer adhered to nowadays. Recent investigations have demonstrated 
that the alterations in mitochondrial ultrastructure and number are non-
specific features of several clinical types of mitochondrial myopathies, and 
may even occur in other diseases such as Duchenne muscular dystrophy 
(Cullen & Fulthorpe, 1975), myotonic dystrophy (Fardeau, 1970), neuroge-
nic atrophy (Shafiq et al., 1968), polymyositis (Chou, 1969), dermatomyosi-
tis (Chew et al., 1977) and adult-onset acid maltase deficiency (Engel & 
Dale, 1968). In these diseases the mitochondrial changes are generally 
observed as a minor feature of the overall pathology. 
The mitochondria may have an enlarged matrix compartment, which 
contains several electron-dense inclusions and only few peripheral cristae. 
The configuration of the cristae may be irregular or concentrica!, whereas 
local dense packing or fusion of the membranes also occur. The cristae may 
be transformed to angular or tubular shapes or may display a honeycomb 
pattern. Alternatively, the mitochondria may be filled up with ill-defined 
membranous structures or with an abundancy of tubulo-vesicular cristae. 
The matrix compartment may contain vesicle-like structures, which appears 
to be particularly related to the occurrence of lactic acidosis (Van Ekeren, 
unpublished results; Post et al., 1985). Occasionally extrusion of the vesicle-
like structures through the mitochondrial membranes is noted. 
A very characteristic, though not pathognomonic presentation of 
mitochondrial pathology is the presence of two distinct types of crystalline 
inclusions. The so-called type I crystals are usually present in the intracristal 
space, whereas the type II crystals are preferentially located in the inter-
membrane space beneath the outer mitochondrial membrane. Their occurren-
ce is suggested to be confined to type I and type II fibres respectively 
(Farrants et al., 1988). These crystals have been demonstrated to be of 
proteinaceous nature and reveal a positive immunoreactivity with antibodies 
to mitochondrial creatine kinase (Stadhouders et al., 1990). 
Aggregation of mitochondria is usually localized beneath the sarcolem-
ma. Whenever a strong increase in the number of mitochondria is present, a 
process of 'budding' from mitochondria is relatively frequently observed. 
The matrix compartment of these mitochondria is transected by two parallel 
membranes, joined at either end by the internal mitochondrial membrane. 
Occasionally the internal membranes of either newly formed matrix com-
partment have already separated. Although these static pictures do not 
indicate the direction in which a process is moving, they are highly sugges-
tive for a process in which 'new' mitochondria are 'pinched off from 
already existing mitochondria (for reviews see DiMauro et al., 1985 and 
Stadhouders & Sengers, 1987). 
Immunohistochemistry was used in combination with enzyme histoche-
mistry in patients with a biochemically defined enzyme deficiency (see 
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below). The immunoreactivity of certain mitochondrial enzymes has been 
shown to be focally or totally decreased in several patients (Bresolin et al., 
1985). However, immunoreactivity may be positive in fibres with an 
enzyme histochemically demonstrated deficiency, as shown for cytochrome 
oxidase in a number of patients (Higuchi et al., 1988). This discongruency 
indicates that some cases of cytochrome oxidase deficiency may be due to 
inactivity of the enzyme rather than to absence of the protein molecule 
(Kogattfa/., 1988). 
Etiology 
It is generally agreed that the mitochondrial pathology observed in 
skeletal muscle tissue from patients with the clinical features of a mitochon-
drial myopathy may be primary or secondary (Sengers et al., 1984; Reich-
mann et al., 1988; Morgan-Hughes et al., 1990). In primary mitochondrial 
myopathies the cause for the clinical and morphological abnormalities is 
thought to be located within one or more of the functional units in the 
mitochondrion itself, whereas in secondary mitochondrial myopathies the 
pathology is thought to be due to some cause which is primarily located 
outside the mitochondrion (Sengers & Stadhouders, 1987). 
Etiology of primary mitochondrial myopathies 
In the search for the etiology of the primary mitochondrial myopathies 
much progress has been made during the last few years. The occurrence of 
maternal inheritance patterns in several families has focused the attention on 
mitochondrial DNA (mtDNA). Mutations in mtDNA were demonstrated in 
several pedigrees but may also occur sporadically (Holt et al, 1989; 
Wallace, 1989). Morgan-Hughes et al. (1990) noted mtDNA deletions in 21 
of 58 patients with mitochondrial myopathies. Assumably causative mtDNA 
mutations were demonstrated for two types of mitochondrial encephalomyo-
pathies clinically known as MERRF (Shoffner et al, 1990) and MELAS 
(Goto et al., 1990). 
The identification of specific mtDNA changes provides new molecular 
criteria for the diagnosis and gives clues to the etiology for some of the 
mitochondrial myopathies. However, since mtDNA only codes for a minori-
ty of the mitochondrial proteins (Anderson et al., 1981) the nuclear genome, 
which codes for the other proteins and controls transport into mitochondria 
and assembly into functional enzyme complexes, may also be involved. For 
most clinically and histopathologically recognized mitochondrial myopathies, 
the molecular biological approach still bears many problems: lack of corres-
pondence between site and size of the deletion and biochemical or clinical 
manifestations; proportion of deleted and normal mtDNA in different organs 
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and at different ages and other factors that render the clinical syndromes 
different in different members of the same family. 
Etiology of secondary mitochondrial myopathies 
The etiological factors in secondary mitochondrial myopathies can be 
tentatively divided in 6 groups: 1. deficiencies; 2. intoxication; 3.disturbed 
regulatory control; 4. hypoxia; 5. disturbed interactions with other cell 
organelles and 6. unindentified causes (Sengers & Stadhouders, 1987). In 
secondary mitochondrial myopathies biochemical studies of mitochondria 
function usually give normal results, since under in vitro conditions the 
influence of the pathogenetic factor(s) is excluded. But even if a deficiency 
of the activity of a specific enzyme can be demonstrated, this may be caused 
by other factors than absence or structural abnormalities of the enzyme 
itself. This situation is exemplified by the induction of complex I (NADH-
ubiquinone reductase) deficiency by hypoxia and reoxygenation, which was 
suggested to be an effect of a disturbance in mitochondrial matrix Ca2+ 
concentration (Darley-Usmar et al., 1990). Another example of secondary 
mitochondrial myopathy was presented by Schapira et al. (1990) who 
demonstrated circulating antibodies against specific mitochondrial proteins in 
two patients indicating autoimmunity as a possible pathogenetic factor. 
The possible role of lipid peroxidation in the etiology 
Phospholipid membranes may react with oxygen free radicals, inducing 
lipidperoxidation. Free radicals are by-products of aerobic metabolism. A 
free radical attack on mitochondrial membrane phospholipids will involve 
disturbances in membrane micro-architecture. Mitochondria are highly 
compartmentalized organelles and the enzymes constituting the electron 
transport chain and the ATP-synthesase complex are embedded within 
membranes. This implicates that integrity of the membranes is of crucial 
importance for a normal function. Membrane damage caused by lipid 
peroxidation may interfere with the metabolic activity of the mitochondria 
and may prevent the incorporation of polypeptide subunits (Stadhouders & 
Sengers, 1987). It was demonstrated that the concentration of radicals in 
tissue which has been ischemic and subsequently reperfused, is significantly 
higher than in normal tissue (Zweier et al., 1987). Maximal oxygen con-
sumption, regarded as a kinetic parameter for cytochrome oxidase activity, 
was drastically decreased in mitochondria isolated from 4 h ischemic and 
subsequently reperfused rat skeletal muscle. The same occurred to the 
concentration of cardiolipin, the phospholipid which is believed to be 
essential for cytochrome oxidase function (Scussi et al., 1990). 
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Biochemical considerations 
In primary mitochondrial myopathies one or more deficient enzymes in 
the mitochondrial metabolism are considered to be the cause for the clinical 
and, if present, histopathological features of the disease. Studies of mito­
chondrial metabolism in vitro have identified a number of different defects 
using several biochemical methods of investigation (Byrne & Trounce, 1985; 
Fischer, 1985; Bookelman et ai, 1978; Trijbels et ai, 1988). The following 
classification of the biochemically identified defects is derived from DiMau­
ro et al. (1987). 
ТжЫе 1 Classiiîcalion of biochemicaUy determined defects in mitochondrial myopathies 
1 Defects of transport 
a CPT deficiency 
b carnitine deficiency 
с defects of FAD uptake (?) 
2 Defects of substrate utilization 
a pymvale carboxylase deficiency 
b pyruvate dehydrogenase complex deficiency 
с defects of B-oxidalion 
3 Defects of the Krebs cycle 
a ñimarase deficiency 
b α-ketoglutarate dehydrogenase deficiency 
4 Defects of oxidation phosphorylation coupling 
a Lull's syndrome (loose coupling of muscle mitochondria) 
5 Defects of the respiratory cham 
a complex I deficiency 
b complex II deficiency C) 
с complex III deficiency 
d complex IV deficiency 
e complex V deficiency 
f combined defects of the respiratory cham components 
CPT carnitine palmitoyl transferase. FAD flavine adenine nucleotide 
In defects concerning the carnitine-acylcarnitine carrier system of group 
1, the histopathological picture is dominated by lipid accumulation instead of 
mitochondrial alterations. Mostly these patients are classified amongst the 
lipid storage diseases instead of within the group of mitochondrial myopa­
thies (Sengers et al., 1984). The absence of specific correlations between 
altered mitochondrial structure and function is further exemplified by 
deficiencies in the intramitochondrial enzymes of the pyruvate dehydrogena­
se complex. In this group of disorders mitochondrial changes are minimal or 
absent (Morgan-Hughes, 1986; Chung et al., 1987). Defects in ß-oxidation 
were also demonstrated, but considering the histopathological features the 
same classifying problems exist as for defects in the carnitine-acylcamitine 
carrier system. Reports on defects in the Krebs cycle and of the oxidation-
phosphorylation coupling are scarce (Zinn et al., 1986; Robinson et al., 
1977; Luft et al., 1962; DiMauro et al., 1976) contrary to reports on 
defects in the respiratory chain (for a review see Morgan-Hughes, 1986). 
With regard to the latter, attention has been particularly focused on cyto-
chrome oxidase (COX, complex Г ), which is deficient in various clinical 
6 
appearances of mitochondrial myopathies, both with and without multisystem 
involvement. In a few patients, suffering from benign infantile mitochondrial 
myopathy, reversible COX deficiency was demonstrated, the disappearance 
of which coincided with improvement of the clinical picture (Zeviani et al., 
1987). This phenomenon may be explained by replacement of mutant 
mitochondria by wild type mitochondria, or by activation of a previously 
inactive form of COX (Higuchi et al, 1988). 
The identification of specific errors of mitochondrial metabolism led to 
a biochemical definition of mitochondrial myopathies (Morgan-Hughes, 
1986). It must be stressed, however, that the myopathies described by the 
morphological term "mitochondrial myopathy" do not necessarily coincide 
with those muscle disorders with demonstrable specific biochemical defects 
of mitochondrial metabolism (Deufel and Gerbitz, 1991). Patients have been 
described who exhibit the clinical and morphological hallmarks of mitochon-
drial myopathy but in whom no biochemical errors can be demonstrated 
(Johnson et al., 1983). As already mentioned a biochemical error may not 
be at the roots of either the clinical or the morphological findings. 
Outline of the present study 
We studied patients with a disturbance of energy metabolism, the cause 
of which appeared not to be located within the mitochondrial metabolism 
itself. They all had exercise intolerance and disabling fatigability as common 
complaints. 
In Section I investigation of two groups of patients is presented. The 
first group of patients suffered from the hereditary syndrome originally 
described by Sengers et al. (1975). It consists of mitochondrial myopathy of 
skeletal muscle, hypertrophic cardiomyopathy, lactic acidosis and congenital 
cataract (nr 21235 in the McKusick register, 1983). Although each constitu-
ent of the syndrome was finally present in every patient, the course of the 
disease demonstrated a wide variety with regard to time of appearance of the 
symptoms and life expectancy. The time lag between the first appearance of 
the various symptoms obscures their coherence. Once the disease is diagno-
sed, the prognosis is virtually unknown. In patients dying soon after birth a 
correct diagnosis is often prevented by the overwhelming cardiorespiratory 
problems. This will prevent appropriate genetic counselling. We investigated 
the clinical course of the disease and attempted to determine prognostic 
factors. The histopathological changes and their possible relation to the 
course of the disease were investigated by qualitative and quantitative studies 
of skeletal muscle structure in patients of different ages. We also studied 
heart muscle tissue from one patient who died at the age of 6 days. 
The second group of patients presented with exercise intolerance and 
disabling fatigability in combination with various additional symptoms and 
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signs. Physical and laboratory examination revealed no or only weak 
indications for the existence of a mitochondrial myopathy and lactacidaemia 
was absent. Microscopic examination of muscle tissue revealed slight 
abnormalities, which did not permit a classifying diagnosis. We investigated 
the correlations of symptoms, signs and laboratory data in 17 patients. The 
course of the complaints was determined in follow-up interviews. Structural 
changes in skeletal muscle were quantified by morphometric analysis. The 
relationship between these quantitative data and symptoms and signs, 
laboratory data and course was statistically analysed. 
In both patient groups biochemical studies of mitochondrial function in 
vitro revealed no abnormalities in patients examined (Sengers et al., 1975, 
1985; Smeitink et al., 1989). Pathogenetic mechanisms are not understood. 
In Section H we consider the possibility that hypoxia might be a 
pathogenetic factor in the investigated patients. An animal model is presen­
ted, intended to investigate whether hypoxic hypoxia (reduction of oxygen 
content in inspired gas mixture) causes alterations in rat skeletal muscle 
which are similar to those observed in the second patient group. 
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Abstract 
The objectives of this study were to describe the course of two forms 
of an hereditary syndrome characterized by congenital cataract, mitochondri­
al myopathy of heart and skeletal muscle and lactic acidosis. We also sought 
to determine clinical, physicochemical and histopathological data which 
might allow early distinction between the two forms. 
We inventarized the ages at which clinical and physicochemical signs 
appeared in 16 patients. In 5 patients, enzymehistochemical and ultrastructu­
ral data of skeletal muscle were inventarized and muscle fibre composition 
was morphometrically analyzed. 
In any particular family only one form of the syndrome occurred. Am­
ongst the patients who did not survive 4 patients died in the neonatal period 
and 7 died at a mean age of 23 years (range 14-34 years). The mean age of 
the survivors was 18 years (range 7'Λ-41 years). Outflow obstruction of the 
left ventricle was noted in 4 deceased patients at variable times prior to 
death. The other deceased patients were not examined, but the cause of 
death was invariably heart failure. In none of the surviving patients outflow 
obstruction was noted. Enzymehistochemical and ultrastructural findings 
were not specific for the course of the disease. In one biopsy, taken at the 
age of Vh months from a patient who survived, strong lipid accumulation 
' European Journal of Pediatrics: revised version accepted 
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was noted. Morphometric analysis showed proliferation of the mitochondria 
in muscle fibres, which increased during the course of the disease. 
Introduction 
The syndrome which is characterised by mitochondrial myopathy of 
both heart and skeletal muscle, congenital cataract and lactic acidosis is 
registered as an autosomally recessive hereditary disease (McKusick, 1990). 
It was first reported in 1975 in 7 patients varying in age from З'/г months to 
20 years (Sengers et al., 1975). Two of these patients died at the ages of 14 
and 21 years, respectively. At that time the other patients were alive. Since 
the first report several aspects from 15 new patients were presented in 
literature (Sengers et al., 1985; Lalive d'Epinay et al, 1986; Van Ekeren et 
al., 1987; Valsson et al., 1988; Smeitink et al., 1989). Three of these 
patients died in the perinatal period and three between 8 months and З'/г 
years. The others died in young adulthood or were alive. 
Based on these data at least two different forms can be distinguished. In 
the fatal neonatal form the infants die within a few days after birth. Patients 
suffering from the relatively benign form may reach adulthood, but most die 
in the second or third decade. As yet no criteria are known by which a 
physician may determine which form is present early in the course of the 
disease. The prognosis for patients who survive the second decennium is 
largely unknown. 
The incidence of the syndrome may be higher than reported. While the 
cardiorespiratory problems are overwhelming in the fatal neonatal form, the 
great time lag between the diagnosis of congenital cataract and the first 
cardiomyopathic symptoms in the relatively benign form may prevent a 
correct diagnosis. Fatigue is often explained by the visual handicap. 
In vitro testing of skeletal muscle mitochondrial function does not 
correlate with the clinical picture (Smeitink et al, 1989). Light microscopy 
is unremarkable and electron microscopy provides the features of a mito­
chondrial myopathy (Sengers et ai, 1985; Van Ekeren et al., 1987). 
It was our intention to describe the progression of each of the two 
forms of the syndrome by studying literature data and hospital files of 16 
patients. We describe in detail the clinical course in two patients with the 
relatively benign form, and in an infant that died after 18 days. In addition 
we qualitatively and qantitatively investigated the ultrastructure of skeletal 
muscle in order to identify possible differences between the two forms of 
the syndrome. 
Patients and methods 
Patients were selected from the literature [Sengers et al., 1975, 1985; 
Cruysberg et al., 1986; Lalive d'Epinay et al., 1986; Van Ekeren et al, 
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1987; Valsson et ai, 1988; Smeitink et al., 1989). Clinical data are summa-
rized in Table 1. Patients of Valsson et al. (1988) are included in Fig. 1, 
but not in Table 1 due to insufficient clinical data. 
Five patients (numbers 1,4,8,12 and 13) were selected for further 
study. Detailed clinical histories from patients 4, 8 and 13 were obtained 
from hospital files. Patient 1 and 12 were described earlier Sengers et al., 
1985; Van Ekeren et al., 1987). Skeletal muscle tissue (soleus muscle in 
patient 12, quadriceps muscle in the others) was re-examined. Results of 
ultrastructural investigation are reported below. Quantitative ultrastructural 
data were derived by morphometric analysis according to the rules of 
Weibel (1979). Methods of morphometric analysis are described elsewhere 
(Van Ekeren et al., 1987). We estimated the volume density (Vv) of 
subsarcolemmal mitochondria (i.e. mitochondria with no myofibrils interpo-
sed between them and the sarcolemma), intermyofibrillar mitochondria, all 
mitochondria, myofibrils and lipid depositions. Reference space was the total 
fibre volume. 
Case histories 
Patient 4, a girl, was born after an uneventful pregnancy and delivery. 
Her parents were healthy and non-consanguineous. Birth weight was 2630 g. 
A few hours after birth she passed through a short period of dyspnoea with 
mild cyanosis. Thereafter she was free from symptoms until the S"1 day, 
when dyspnoea re-occurred. She was referred to our clinic at the age of 16 
days. Physical examination showed a severly ill, dyspnoic and cyanotic baby 
with bilateral cataracts. A slight ejection murmur was heard. The rounded 
liver edge was 5 cm below the costal margin. Systolic blood pressure was 
65 mmHg. Signs of neuromuscular disease were not noted. 
Chest X-ray showed cardiomegaly. The electrocardiogram showed a 
short PQ time (0.07-0.06 sec) and left ventricular hypertrophy with abnor-
mal intraventricular conduction. Echocardiography showed hypertrophy of 
the posterior wall of the left ventricle (0.97 mm) and, more pronounced, of 
the interventricular septum (0.91 mm). Mitral valve velocity was 7-34 
mm/sec. These data suggest a hypertrophic obstructive cardiomyopathy. 
Serum lactic acid levels were seriously increased to 8 mmol/L. CK was 
mildly increased. 
Despite conventional treatment the patient's condition worsened. She 
succumbed on the second hospital day. With informed consent of the 
parents, biopsies of quadriceps and heart muscle were taken within 20 
minutes of death. 
Patient 8, a girl, was born after an uneventful pregnancy and delivery. 
She was the 9,h child of healthy parents. Two elder sisters died at the ages 
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of 19 and 34 years due to the same disorder. Birthweight was 3000 g. 
Shortly after birth bilateral cataracts were noted, which were surgically 
extracted. Psychomotor development was normal. 
At the age of 7 years she visited the paediatric outpatient clinic with 
complaints about exercise intolerance. She experienced palpitations and went 
extremely pale during exercise. Physical examination revealed no abnormali­
ties, except a grade I ejection murmur. Chest X-ray showed a slightly 
rounded heart contour but no cardiomegaly. ECG showed all signs of a 
Wolff-Parkinson-White (WPW) depolarisation pattern. During the next two 
years she experienced a few periods of tachycardia which necessitated 
eraldine therapy. At the age of 9 years, ECG showed a very short PQ time 
(0.06 s), a large delta wave and negative Ρ peaks, consistent with severe left 
ventricle hypertrophy, WPW syndrome and myocardial abormalities. 
Vectorcardiography indicated the existence of a subvalvular aortic stenosis. 
Serum lactic acid rose from 10 mmol/L at rest to 48 mmol/L after 40 min 
of relaxed walking. ß-Blocking therapy was started. 
At the age of 19 years her physical capacity started to decrease rapidly. 
Now, for the first time, chest X-ray showed cardiomegaly. Doppler echocar-
diography revealed hypertrophy of the posterior wall of the left ventricle and 
more pronounced of the septum as well as abnormal mitral valve move-
ments, indicating hypertrophic obstructive cardiomyopathy. Sixteen months 
later the Doppler echocardiography indicated a congestive cardiomyopathy 
with a wide left ventricle. ß-Blocking therapy was replaced by digitalis. 
Until the age of 23'/2 years the shortening fraction of the left ventricle 
decreased from 20% to approximately 4% (normal 30%). Finally, after 
several periods of nocturnal dyspnoea, she succumbed due to cardiac failure 
at the age of 24 years. 
Patient 13 was the first of two children of healthy parents. She was 
born after an uneventful pregnancy and delivery. Birthweight was 2900 g. 
After З'Л months a health centre physician noted growth retardation and a 
slight delay in psychomotor development. The parents said that she never 
finished her feeding bottle. 
Physical examination revealed bilateral cataracts and a slight muscular 
hypotonia, mainly proximally located. She could not lift her head and did 
not contact persons around her. A grade 2 systolic murmur was heard. 
Chest X-ray showed cardiomegaly. ECG showed a short PQ time and 
indicated severe left ventricle hypertrophy. Acid alpha-glucosidase activity 
was normal in leucocytes and skeletal muscle tissue, excluding Pompe 
disease. Microscopic examination of muscle tissue revealed unusual lipid 
accumulation amongst other abnormalities (see below). Serum lactic acid 
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level was 10 mmol/L (normal < 1.8). She was treated with sodium bicarbo­
nate. 
At 7 months, when cataract extraction was performed, chest X-ray 
showed an even more enlarged heart. Although slight psychomotor retardati­
on remained manifest (unsupported walking at 24 months) she developed 
steadily during the subsequent years. Growth rate was normal, but her 
height remained under PIO. 
At the age of 51/г years she complained of pain in the heart region. 
ECG showed incomplete right bundle branch block and STT depression in 
addition to the already known pathology. Echocardiography showed hyper­
trophy of the septum and posterior wall of the left ventricle, but no obstruc­
tion was noted. ß-Blocking therapy was started. 
In the following 9 years the clinical picture remained stable. Findings 
on ECG did not alter; occasionally ST pathology was noted. On chest X-ray 
the signs of cardiomegaly dissappeared, but a rounded contour of the left 
ventricle and apex remained visible. Doppler echocardiography showed 
normal function of left ventricle. At the age of 14'/2 years exercise intole-
rance increased. She experienced nausea after exertion and turned extremely 
pale. At age 16 she had difficulties in walking upstairs carrying a heavy 
school bag. At the age of 19 years serum lactic acid values were also 
slightly raised at rest. At the age of 20 years she was committed to a 
wheelchair due to exercise intolerance. Her complaints cannot be explained 
by cardiac dysfunction as demonstrated by recent Doppler echocardiography. 
Results 
Clincal data (Table 1) 
In all patients bilateral cataracts were noted in the first months of life, 
except for patient 14. Cataracts were extracted in the first year of life, 
except in those who died in the perinatal period and in patient 14. 
Hypertrophic obstructive cardiomyopathy was noted soon after birth in 
those who died perinatally. In the other patients the age of the first clinical 
manifestation of cardiomyopathy was not related to the course of the 
disease. However, the assessment of left ventricle outflow obstruction 
appears to predict a fatal outcome. In 5 surviving patients no obstruction 
was observed despite regular check-ups. 
Skeletal muscle pathology and lactic acid level were usually only 
examined when the syndrome was suspected. Our data indicate that these 
signs were also present during childhood in surviving patients. 
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Table 1 Clinical data 
Patient 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Family 
A 
A 
В 
С 
D 
D 
D 
E 
E 
E 
F 
F 
G 
H 
J 
J 
Sot Cataract 
m 
m 
m 
m 
m 
f 
m 
1 d 
9 d(PM) 
< 1 0 d 
16 d 
1 mo 
10 d 
5 d 
1 mo 
1 mo 
14 d 
5 yrs 
1 mo 
З'Л mos 
3 mos 
2'Л mos 
3 mos 
Cardiomyopathy 
1 d 
1 d 
< 1 0 d 
16 d 
14 yrs 
2 mos 
14 yrs 
7 yrs 
20 yrs 
8 yrs 
IByni 
33 yre 
З'А mos 
6'/4 yrs 
Vh yrs 
4'/4 yrs 
Muscul 
aorta 
stenosis 
Sd 
nr 
nr 
16 d 
nr 
nr 
nr 
9 yrs 
nr 
14 yrs 
nr 
I 
_ 1 
_ l 
1 
1 
Skeletal 
muscle 
myopathy 
7 d(PM) 
nr 
10 d(PM) 
18 d(PM) 
nr 
nr 
nr 
10',$ yrs 
nr 
nr 
nr 
33 yrs 
4 mos 
nr' 
nr
1 
nr
1 
Lactic 
acidaemia 
1 d 
nr 
< 1 0 d 
16 d 
14 yrs 
nr 
nr 
lOW yrs 
nr 
16 yrs 
nr 
25 yrs 
4 mos 
6 mos 
8'¿yrs 
4'^ yrs 
Deceased 
7 d 
9 d 
10 d 
18 d 
14 yrs 
25 yrs 
21 yrs 
24 yrs 
34 yrs 
19 yrs 
23 yrs 
alive (41 yrs) 
alive (20 yrs) 
alive (10 yrs) 
alive (11'/4 yrs) 
alive O'/i yrs) 
m male, f female, nr not registered, PM post mortem, ' no signs of obstruction until present, 1 skeletal muscle biopsy was 
not allowed, however clinical signs of skeletal muscle myopathy were present since birth 
The ages of death are graphically presented in Fig. 1. Four patients 
died in the neonatal period. Seven patients died at a mean age of 23 years 
(range 14-34 years). Death cause was invariably heart failure. The others 
were alive (mean age 18 years, range 7l/2-41 years). From Table 1 it 
appears that all patients in one family either die in the neonatal period or 
belong to the group which survives the first decade. 
Light microscopy 
Light microscopy was unremarkable, particularly no ragged red fibres 
were noted. Type I predominance was seen in one patient (12). 
50 
40 
RELATIVE FREQUENCY 
20 -
( M O N T H 8 - 4 2 M O N T H S * 
AGE OF DEATH 
U - 34 YEARS 
Fig.l Frequency distribution of ages of death. * Patients of Valsson et al. (1988) 
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Ultrastructure of skeletal muscle 
Table 2 lists the ultrastructural findings in skeletal muscle. For a 
detailed description, the reader is referred to Sengers et al. (1975, 1985) 
and Van Ekeren et al. (1987). In patient 13, which is the only patient 
suffering from the relatively benign form who was biopsied at infancy, the 
mitochondrial ultrastructure is fairly well preserved. In contrast to the other 
patients, this biopsy exhibits a large amount of small lipid droplets, which 
are typically arranged between the myofibrils in close contact with mito-
chondria (Fig. 2). 
Table 2 Ultrastructural findings 
lipid glycogen abnormal crystalline matrix 
storage storage mitochondria inclusions vesicles 
m mitochon. in mitochon-
patient 
1 + + + + + 
4 - + + - + 
8 + - + + 
12 - + + + + 
13 + + +' 
1
 minimal abnormalities 
Fïg.2 Skeletal muscle tissue of patient 13. Lipid droplets (arrows) in close association with 
mitochondria, occassionally displacing the regular array of myofilaments. Uranyl acetate lead 
citrate staining, ultrathin section, χ 7800 
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Morphometñc analysis. 
Table 3 shows the results of morphometric analysis. All our patients 
demonstrated an increased volume density of subsarcolemmal mitochondria. 
In addition, the biopsies from patient 8 and 12 (age at which biopsy was 
taken lO'/i and 33 years, respectively) showed an increased volume density 
of intermyofibrillar mitochondria with regard to the biopsies from patient 
13, also suffering from the relatively benign form (age of biopsy 4 months) 
and patients 1 and 4, suffering from the fatal neonatal form. All our patients 
had a lower volume density of myofibrils than healthy persons. 
Table 3 Ullraslructural composition of skeletal muscle Fibres 
Biopsy age 
Sex 
Vv[mi,n 
Vv[ms,n 
Vv[ml,f] 
Vv[mf,n 
VJli.n 
patients' 
7d 
m 
5 2 ± 0 2 
13 ± 0 2 
6 5 ± 0 3 
72 2 ± 13 
0 2 ± 006 
17 d 
f 
4 0 ± 0 2 
1 6 ± 0 2 
5 7 ± 0 3 
70 0 ± 17 
0 2 ± 006 
4 mos 
f 
3 8 ± 0 3 
1 3 ± 0 2 
5 1 ± 0 3 
70 8 ± 1 3 
3 3 + 0 5 
WA yrs 
f 
4 8 ± 0 3 
12 ± 0 3 
6 0 ± 0 4 
73 0 ± 1 1 
0 9 ± 0 1 
33 yrs 
f 
4 8 ± 0 4 
2 2 ± 0 7 
6 9 ± 0 7 
76 2 ± 1 7 
0 9 ± 0 2 
controls1 
28 ± 8 yrs 
m 
5 0 ± 0 6 
0 2 ± 004 
5 2 + 0 7 
85 9 ± 2 4 
0 3 ± 0 2 
25 ± 8 yrs 
f 
4 0 ± 0 4 
0 1 ± 0 2 
4 1 ± 0 5 
87 4 ± 10 
0 4 ± 0 2 
volume densities ± standard error of the ratio, mi interniyofibnllar mitochondna, ms subsarcolcmmal mitochondna, ml 
all mitochondna, mf myofibnls, h lipid, Γ muscle fibre, ' patients 1, 4, 13, 8 and 12 respectively, ' data from Hoppeler 
et al (1973), mean age ± standard deviation of 9 men and 3 women 
Discussion 
This syndrome appears to have two variants: a fatal neonatal form and 
a relatively benign form. The physical signs are alike in both, but life 
expectancy differs greatly. In both forms bilateral cataracts are typically 
present from birth (Cruysberg et ai, 1986). In the fatal neonatal form 
hypertrophic obstructive cardiomyopathy is recognized within days after 
birth and leads to death within weeks. In the relatively benign form hyper­
trophic cardiomyopathy may present at any time between birth and adult­
hood, but there seems to be a tendency towards ages past the toddler period. 
These patients had cataract extraction in their first year of life, showing that 
cataracts may be the only sign of the disease in early childhood. If during 
the course of the relatively benign form, left ventricle outflow obstruction 
develops, life expectancy is seriously shortened. The prognosis in patients 
without subvalvular aortic stenosis is dependent on the skeletal muscle 
metabolic function. It may vary between a moderate exercise intolerance 
(Sengers et al., 1985) and commitment to a wheelchair. 
In both forms of the syndrome, lactacidaemia and mitochondrial 
myopathy are present from birth. We cannot exclude that the ultrastructural 
features change during the course of the relatively benign form since our 
youngest biopsied patient with the relatively benign form demonstrated 
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considerably more lipid storage and less mitochondrial abnormalities than 
both deceased and surviving elder patients. 
Our morphometric data indicate that proliferation of subsarcolemmal 
mitochondria occurred in skeletal muscle fibres of all patients, and that 
intermyofibrillar mitochondria proliferated during the course of the disease. 
These findings may represent an attempt by the muscle fibre to compensate 
for a deficit in energy production. The excessive volume density of subsar-
colemmal mitochondria in our eldest living patient, who is relatively 
healthy, suggests that compensatory hyperplasia of the chondriome may play 
a role in the patient's quality of life. Thus morphometric analysis indicates a 
difference in skeletal muscle composition between the different stages of the 
disease, but does not provide criteria by which the forms can be discrimi-
nated. The decrease of the volume density of myofibrils may be explained 
by the dilatation of the intermyofibrillar spaces (Sengers et al., 1985; Van 
Ekerene/ al, 1987). 
The syndrome is transmitted as an autosomal recessive disease (McKu-
sick, 1983). Recognition of the syndrome is of utmost importance for 
genetic counselling. The mitochondrial hypertrophic cardiomyopathy (Van 
Ekeren et al., 1987) should not be confused with idiopathic hypertrophic 
cardiomyopathy. Since the latter has a autosomal dominant inheritance or 
occurs sporadically (Maron et al., 1987), the probability of repetition in the 
absence of hypertrophic cardiomyopathy in either of the parents will be 
regarded as minimal, whereas this probability is 25% in the case of 
mitochondrial hypertrophic cardiomyopathy as part of the syndrome. The 
occurrence of only one of the two forms of the syndrome in each family 
suggests that the two forms are caused by different mutations. 
The metabolic cause for the disease is unknown. Smeitink et al., (1989) 
excluded a deficiency in the pyruvate dehydrogenase complex, the citric acid 
cycle and the respiratory chain in the fatal neonatal form. 
We conclude that no clinical criteria exist which definitely discriminate 
between the fatal neonatal and the relatively benign form. However, left 
ventricle outflow obstruction in a neonate with the syndrome strongly 
indicates the fatal neonatal form. If a propositus has an affected sib, he will 
probably suffer from the same form. In the relatively benign form occurren-
ce of left ventricle outflow obstruction seriously shortens life expectancy. 
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Summary 
A six day old boy died from an hereditary hypertrophic cardiomyopathy 
which was associated with mitochondrial myopathy of skeletal muscle, 
congenital cataract and lactic acidosis. In heart and skeletal muscle identical 
mitochondrial abnormalities were found: paucity and abnormal arrangement 
of cristae, formation and extrusion of vesicle-like structures and crystalline 
inclusions in the matrix compartment. Electron-cytochemistry revealed that 
only part of the mitochondria reacted positively for cytochrome oxidase 
activity. Morphometric analysis indicated that the cardiomegaly was due to 
cellular hypertrophy, which might be caused by an increase in the mitochon­
drial mass. The cardiac hypertrophy in this syndrome can be classified 
histopathologically as mitochondrial hypertrophic cardiomyopathy. 
Introduction 
The association of hypertrophic cardiomyopathy with mitochondrial 
myopathy of skeletal muscle, congenital cataract and lactic acidosis after 
exercise is known as a syndrome which follows an autosomal recessive 
pattern of inheritance (Sengers et al., 1975). The syndrome is registered 
' Virchows Arch A (1987) 412:47-52 (modified lay out) 
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number 21235 on the McKusick register. The histopathological abnormalities 
in skeletal muscle were described previously (Sengers et al., 1975, 1985). 
They include abnormal arrangement and loss of mitochondrial cristae, 
crystalline inclusions in the mitochondria and deposition of lipid and 
glycogen. 
This syndrome is either fatal in infancy or follows a more benign 
course with death occurring in adolescence or young adulthood (unpublished 
data). Recently we had the opportunity to study the histopathological 
changes in the heart and skeletal muscle of an infant who suffered from the 
fatal infantile form of the syndrome. To our knowledge the histopathology 
of heart and skeletal muscle in this infantile form of this syndrome has not 
been described. 
Case report 
The patient, a boy, was born after an uneventful pregnancy and 
delivery as the second child of healthy, non-consanguinous parents. His 
birth weight was 3250 g and the Apgar scores were 7 and 10 at 1 and 10 
min, respectively. Tachypnoea and perioral cyanosis were noted within a 
few hours after birth. On the first day of life radiological and electrocardio-
graphic examination indicated the presence of right ventricle hypertrophy. 
Echocardiography revealed septal hypertrophy (septum thickness 6 mm; left 
ventricular posterior wall thickness 4 mm; right ventricular anterior wall 
thickness 3 mm; normally below 4.5, 4.2, and 3.4 mm respectively). 
Repeated echocardiography at the fourth day showed an increase in septum 
thickness up to 8 mm. Cataract of the anterior capsules of the lenses was 
noted at that time. The lactic acid concentration in blood was 12 mmol/L 
(normal < 1.8), in urine 1.57 mmol/mmol creatine (normal < 0.2) and in 
cerebrospinal fluid 12 mmol/L (normaKl.8). The usual therapeutic proce-
dures were unsuccessful and at the age of six days the patient died due to 
cardiorespiratory insufficiency. With informed consent of the parents 
specimens were taken from the apex of the left ventricle and from the right 
femoris muscle within ten minutes after death. Autopsy took place four 
hours later. Results of the examination of heart and skeletal muscle are 
described in detail below. Apart from the bilateral cataracts no relevant 
abnormalities were noted in other organs and tissues. The first child of this 
couple, also a boy, died eight days after birth; at autopsy hypertrophic 
cardiomyopathy was found. Eyes and skeletal muscle were not examined. 
Examination of both parents by an ophthalmologist (including split lamp 
examination) and by a cardiologist (including electrocardiography and 
echocardiography) excluded ophthalmological and cardiological disorders. 
Since the parents had no complaints of muscle disease a biopsy was not 
performed. Urine analysis revealed normal lactic acid levels. The parents of 
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our patient were not aware of abnormalities of eyes, heart or skeletal 
muscular system in other members of their family. 
Material and methods 
Autopsy material was fixed in formalin and embedded in paraffin. 
Sections were stained with haematoxylin-eosin and also for elastin and 
reticulin. The specimens of skeletal muscle and myocardium taken 10 min 
after death were immediately fixed in 2% buffered glutaraldehyde, postfixed 
in 2% buffered osmium tetroxide and embedded in Epon 812. Semithin 
Epon sections were stained with toluidine blue, with PAS or were treated 
with para-phenylene diamine to demonstrate fat deposition. Ultrathin 
sections were contrasted with uranyl acetate and lead citrate. For the 
electronmicroscopic histochemical demonstration of cytochrome oxidase 
activity vibratome sections were treated according to Seligman et al. (1968) 
with modifications according to Angermüller and Fahimi (1981). 
Profile diameters of cardiac muscle cells were estimated on projected 
images of the 10 μηι reticulin stained sections. In cases of ellipsoid profiles 
the lesser diameter was considered to be the profile diameter. A MOP-
Videoplan measuring instrument (Kontron, Federal Republic of Germany) 
was used for morphometric measurement. Electron micrographs for the esti­
mation of volume densities of myofibrils, mitochondria, nuclei and lipid 
droplets were obtained by systematic random sampling. The point counting 
method described by Weibel (1979) was used for the morphometric-stereolo-
gical procedure. A total area of 0.01 mm2 heart tissue was analysed at a 
final magnification of 21600 x. 
Results 
Examination of the heart 
The whole heart was severely hypertrophied and it weighed 47.5 g 
(normal weight 23 g; Kissane, 1975). This hypertrophy was most pronoun­
ced in the ventricular septum (Fig. 1). The ventricular and atrial lumina 
were slightly dilated. 
A slight subendocardial interstitial fibrosis, mainly in the septum, is 
present. Fibre disarray is not noted. Neither inflammatory cells nor necrotic 
fibres are seen. Many cardiac muscle cells show vacuolisation. Paraphenyle-
nediamine staining reveals large areas of lipid droplet deposition (Fig. 2). 
PAS-positive material is present in localized areas. Subepicardial and 
perivascular regions are less affected by lipid and glycogen accumulation. 
Electronmicroscopically the sarcolemma plus lamina basalis as well as 
the intercalated discs of the cardiac muscle cells appear normal. One or two 
myofibrils, consisting of partly dispersed myofilaments, are present beneath 
the sarcolemma. Lipofuscin is seen. The nuclei contain normally dispersed 
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chromatin; karyolysis or karyorrhexis is not noted. In part of the cardiac 
muscle cells the nuclei are surrounded by "empty" sarcoplasmic zones, but 
mostly the perinuclear areas are filled with closely packed, abnormal 
mitochondria and 1 to 6 μτη large lipid droplets (Fig. 3a). The mitochondria 
are rounded and uniformly large. The mitochondria characteristically contain 
one or two cristae, lying immediately beneath the outer membrane. Some of 
the mitochondria contain stacks of transversely oriented cristae. Only about 
half of the mitochondria show cytochrome oxidase activity in the inner 
membrane or, if present, in the remnants of cristae (Fig. 4). 
Fig.2 Heart muscle cells of lefi ventricle, some of which contain large lipid depositions. 
Indistinct vacuolisation. Space bar 10 μτη. Para-phenylene diamine stained section, χ 800 
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Fig.3.a Heart muscle cell of left ventricle almost completely filled with abnormal mitochondria. 
Vesicles in mitochondria (arrows) and in cytoplasm (arrowheads). Lipid deposition and few 
myofibrils. Space bar 1 μ/η. Uranyl acetate led citrate staining, χ 8000. h Vesicle emerging from 
mitochondrion. Space bar 0.25 ¡m. Uranyl acetate led citrate staining, χ 35 000. с Crystalline 
inclusion in matrix space. Space bar 0.25 μ/π. Uranyl acetate lead citrate staining, χ 33 500 
Another characteristic finding is the presence of matrix vesicles which 
are usually limited by two membranes. Many mitochondrial profiles suggest 
a process of extrusion of these vesicles into the cytoplasmic space (Fig. 3b). 
The same type of vesicle is seen in the sarcoplasm. In the matrix com­
partment dense granules are absent. However, rectangular crystalline 
inclusions are regularly seen (Fig. 3c). 
oq 
The cardiac muscle cells had a mean diameter of 9.9 ± 2.8 μηι (mean 
± standard deviation; η = 150; normal 6 μηι, David et al., 1978). In Table 
1 the results of stereologic analysis are summarized. Since such data are not 
available from age matched controls, data from children aged 5-15 years are 
included in the table. With exception of the volume density of nuclei, which 
decreases during postnatal life, no major changes in the relative contents of 
the cardiac muscle cells occur during postnatal life (Page et al,. 1974; 
David et al. 1978). 
Table 1. Results of stereological analysis of samples of the left ventricle and literature data 
Volume fraction per total tissue volume 
Volume density of myocardiocytes 
Volume fractions per myocardial tissue volume 
Volume density of nuclei 
Volume density of myofibrils 
Volume density of mitochondna 
Volume density of lipid 
Patient 
Mean [%] 
± SER 
68.8 ± 2.1 
6.9 ± 1.5 
29.0 ± 1.6 
30.1 ± 1.2 
3.4 ± 0.5 
Literature 
data 
76.1 
6.5 
47.1 
34.5 
not registered 
SER: Standard Error of the Ratio. Literature data from Fleischer et al., (1978) 
Fïg.4 Electron micrograph of abnormal mitochondria of heart muscle cell of lefi ventricle, 
stained for cytochrome oxidase activity. Darkly stained membranes are cytochrome oxidase 
positive, while the other membranes do not show activity. Space bar 0.5 μ/η. χ 17 000 
Examination of skeletal muscle 
In the skeletal muscle tissue no necrotic fibres occur. The modified 
Gomori trichrome staining does not reveal ragged-red fibres. Accumulations 
of PAS-positive material are seen in the enlarged intermyofibrillar and 
subsarcolemmal spaces, incidently forming subsarcolemmal blebs. 
In electron microscopy the enlarged intermyofibrillar and subsarcolem­
mal spaces are filled with abnormal mitochondria and accumulations of gly­
cogen particles. The skeletal muscle mitochondria are irregularly outlined 
and partly have the same abnormalities as described above regarding the 
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heart muscle mitochondria (Fig. 5). Cytochrome oxidase activity is lacking 
in about half of the mitochondria. In particular many mitochondria possess 
vesicles. Matrix crystals are also seen occasionally. The myofibrils appear 
normal with only incidentally some derangement of the sarcomere pattern. 
Lipofuscin is occasionally seen. 
This patient suffered from hypertrophic cardiomyopathy, mitochondrial 
myopathy of skeletal muscle, congenital cataract and lactic acidosis. We 
have knowledge of 17 patients with this syndrome, eight of which are 
described in literature (Sengers et al., 1975, 1985). Four patients died 
within the first months of life and six died between the age of 14 and 23 
years. The cause of death in all these patients was cardiorespiratory insuffi­
ciency. The age of the living patients varies between 15 and 33 years. They 
all suffer from a moderate to severe exercise intolerance. In all cases 
surgical extraction of the cataracts had to be performed at young age. 
In our patient there was increasing hypertrophy of the heart in the six 
days of life. The distinctly increased mean cardiac muscle cell diameter indi­
cates that the heart hypertrophy must mainly be due to hypertrophy of the 
cardiac muscle cells. The morphometric studies indicate that the mitochon­
dria in particular contribute to this cellular hypertrophy. Assuming that the 
tissue samples studied are representative for all cardiac muscle cells and 
assuming an equal specific gravity for all tissue components, it can be 
calculated that the total mitochondrial mass in the cardiac muscle cells of 
our patient is 9.7 g (mass of heart χ cardiac muscle cell volume density/100 
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χ mitochondria volume density/100). The total mitochondrial mass of the 
cardiac muscle cells of a healthy newborn (heart mass 23 g; Rissane et al. 
1975) can be calculated to be 6.1 g, using the stereological data of Fleischer 
et al. (1978). This would indicate an increase of the mitochondrial mass in 
the heart of our patient of about 60%. Myofibrils do not contribute much to 
the hypertrophy since the increase in myofibrillar mass is only about 14% 
(calculations as described above). The stereological data of Fleischer et al. 
(1978) used above are obtained from 5 to 15 year old children. Use of these 
data in our calculations on the heart of a newborn seems justified since there 
are no major changes in the mitochondrial and myofibrillar volume densities 
during postnatal life (Page et al., 1974; David et al., 1978). Lipid ac­
cumulation may also have contributed to the cellular hypertrophy, but to a 
far lesser extent since lipid volume density is only about 1/10th of mito­
chondrial volume density. 
The increase in mitochondrial mass may be an attempt of the cardiac 
muscle cell to compensate for a defect in mitochondrial function. Deficient 
mitochondrial function is indicated by the marked lactic acidosis in our 
patient and by the observed lipid and glycogen accumulation. Furthermore 
the electron-cytochemical findings of cytochrome oxidase activity in our 
patient show that about half of the mitochondria in both heart and skeletal 
muscle fibre react negatively. It is important to note, however, that we do 
not have comparative information about the cytochrome oxidase activity in 
the heart and skeletal muscle of healthy newborns. Negatively reacting 
mitochondria have also been demonstrated in the skeletal muscle fibres of 
patients with progressive external ophthalmoplegia (Müller-Höcker et al., 
1983). In the fibres of these patients, where there is also an increase in 
mitochondrial mass, all mitochondria in one fibre are either positive or 
negative. Other authors have used the term mitochondrial cardiomyopathy 
(Hübner and Grantzow 1983; Langes et al., 1985; Hübner et al, 1986) for 
myocardial disease in which the most prominent histopathological findings 
are structural and/or quantitative changes in the chondrioma of the cardiac 
muscle cell. The analogy with description in skeletal muscle pathology, in 
which mitochondrial myopathy is a generally accepted term (Sengers et al., 
1984; DiMauro et al., 1985) seems to justify the use of the term mitochon-
drial cardiomyopathy for these diseases. This is supported by the fact that 
the same mitochondrial changes are present in both heart and skeletal muscle 
in our patient. Besides the pathogenetic characterization "mitochondrial 
cardiomyopathy" we also use the descriptive term "hypertrophic". The latter 
term seems to be justified, not only by the severe hypertrophy of the whole 
heart, but also by the striking, preponderant thickening of the ventricular 
septum. The hypertrophic mitochondrial variant of cardiomyopathy must not 
be mistaken for the idiopathic form, which is characterized by cardiac 
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muscle cell disorganization (Marón et al., 1987) without any metabolic and 
usually also without dystrophic alterations of the myocardium. 
Mitochondrial cardiomyopathy is also known to occur in the Leigh 
syndrome (Langes et al., 1985) and in the Kearns Sayre syndrome (Hübner 
et al., 1986). Comparing the findings in these reports with our findings, the 
increase of the mitochondrial mass of the cardiac muscle cell seems to be 
the most consistent finding in mitochondrial cardiomyopathy. The extensive 
fat deposition, the occurrence of intramitochondrial vesicles and the presence 
of crystalline inclusions in the matrix compartment (and not in the intracrys-
tal space as usual, cf Stadhouders and Sengers, 1987), are findings which 
have not been described by the above mentioned authors. 
Electronlucent vesicles which seem to emerge from the mitochondrion 
have been seen in rabbit hearts which were rendered ischaemic and conse-
quently reperfused (Post et al., 1985). The occurrence of these vesicles was 
dedicated to a pH drop and a rise in Ca2+ concentration. Our patient suf-
fered from severe lactic acidosis, which may also have caused a strong 
decrement in the intracellular pH. 
In summary it can be stated that the histopathological alterations of the 
heart muscle in the infantile form of the syndrome of hypertrophic car-
diomyopathy, mitochondrial myopathy of skeletal muscle, cataract and lactic 
acidosis can best be described as a mitochondrial hypertrophic cardiomyopa-
thy. In our case cellular hypertrophy plays an important role in the enlarge-
ment of the heart. Of all structural cellular components the mitochondria 
appear to contribute most to the cellular hypertrophy. 
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Abstract 
Muscle biopsies of 17 children with exercise intolerance and miscella-
neous other symptoms and signs showed changes in mitochondrial content. 
The patients could not be classified according to known criteria. The 
histopathological changes were quantified by morphometric analysis and the 
clinical data were statistically analysed to detect intercorrelations. After a 
mean follow-up period of 6.8 years (range 0.5 - 13.6) patients were re-
examined and the course of the disease was determined. 
No clinical entity could be established. None of the patients showed 
aggravation of the exercise intolerance, but 71% noted no improvement. 
Fifty-nine percent had an increased volume density of peripheral mitochon-
dria. Based on clinical history, histopathological changes and course we 
suggest that some of these patients suffer from a yet unknown disturbance in 
energy metabolism. Recognition of these patients is important for appropria-
te counseling. 
Introduction 
Diagnosis in patients suspected of having a neuromuscular disease is to 
a great extent based on the study of biopsied tissue. Unfortunately, nonspe-
cific abnormalities are found in a considerable number of specimens. 
Although the patients may be severely invalidated by the disease, the 
' European Journal of Pediatrics (1991) 150:744-750 (modified lay out) 
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clinician is unable to offer appropriate advice or therapy due to the lack of a 
definitive diagnosis. 
The aim of this study was to investigate the relationship between 
symptoms and signs, laboratory data, histopathological data and the course 
of the disease in patients with exercise intolerance in combination with other 
clinical signs of myopathy and non-specific abnormalities in skeletal muscle 
tissue. We analyzed our data to answer three questions. 1. Can the symp-
toms and signs be categorized to form a clinical entity? 2. What is the 
relationship between clinical data, physicochemical data, course of the 
disease and the histopathological findings? 3. Which factors are of prognos-
tic significance? 
At the first consultation no diagnosis was made in these patients. We 
describe the clinical manifestations and the course of the disorder during 6 
months-13 years. Their skeletal muscle tissue demonstrated alterations in the 
amount of subsarcolemmal mitochondria, which were quantified by mor-
phometric analysis. 
Patients 
Patients with exercise intolerance and disabling fatigability not caused 
by a well known neuromuscular disease were selected for this study. 
Fatigability was regarded as disabling when the patients could not perform 
all daily activities normal for their ages and training programs did not 
distinctly raise their physical capacity. The patients tended to avoid physical-
ly strenuous situations. Most patients or their parents did not consider the 
condition as abnormal until they were asked to compete with persons of the 
same age, as in starting a school or a job. In adulthood some of the patients 
were excused from military service and others received a (partial) sickness 
benefit from the Social Security. 
The age, sex, and relevant clinical and laboratory findings at the time 
of first consultation are listed in Table 1. Lactic acidosis was absent in all 
patients. No indications for lipid and/or glycogen storage disease could be 
demonstrated. Pregnancies had been normal. None of the patients showed 
signs of cardiomyopathy. Family history was negative for neuromuscular 
diseases in all patients, except in patient 15 and 16 which were sibs. 
Case history (patient 17) 
The clinical and personal history given below are representative for the 
other patients. Since she is the eldest patient in our group who was biopsied, 
her story covers the course from birth to adolescence. Although personal 
circumstances in other patients may be different the character of the com-
plaints was remarkably similar throughout the patient group. 
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Table 1. Summary of iclevanl clinical and laboratory findings al fmt consultation in patienta with exerciae intolerance 
Patient No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 IS 16 17 
Sex M M M M M F M M M M F F M F M F F 
Age at biopsy (yean) 3 6 5 8 6 0 6 3 7 9 8 6 8 8 8 8 10 7 11 2 12 0 12 2 13 2 14 3 14 3 16 S 17 0 
Seventy of exercise intolerance' ++ ++ + ++ + ++ + + ++ ++ ++ + ++ ь* ++ ++ +•»• 
Age of firel symptoms (years) 0 0 0 0 0 0 0 4 0 0 6 6 0 1 14 16 0 
PennaUl asphyxia + . _ _ _ _ _
 + + _ _ 
Menial retardation - - - + + - + + + + + 
Motor retardation1 + + - + + + + - + + - + 
Muscle weakness -»- + + - - + + + H - - + 
Hypotonia + - + + + + + + + + - - - - - - + 
Length < PIO - • - +
 + + 
Skeletal deformations1 . . - - - . - - _ + _ _ .
 + _ . + 
Neurological symptoms4 - . - + + - - + + 
Mild CK elevation - - + + + + - + - + - - - + + - -
EMG findings1 - nr nr my - my - - - η - my - nr nr -
EEG findings - nr nr + - nr + nr + nr nr + nr nr -
Exercise lest* nr nr - - nr + nr + - + nr nr + + -
M male, F female, nr not registered due to organizational reasons, ' + moderate, + + severe, 3 according to the Denver 
Scrceningstest for motor development, 1 compnsing genua valga, pedes plani and pedes excavati, 4 case 4 and 8 cerebellar signs, 
case 5 mild hemiparcsis, case 8 assymmetnc movement pattern, case 9 mild myotonia, 1 my myopathic change, η neurogenic 
change,4 completed, + not completed due to exhaustion 
Clinical history 
She was the second of three children of healthy, non-consanguineous 
parents. Pregnancy and delivery were uncomplicated. Hypotonia was noted 
from birth; motor development was qualitatively normal but slightly delayed. 
She walked unsupported at 19 months. As a toddler she had some epileptoid 
fits. Electroencephalography demonstrated no abnormalities and the fits were 
designated as crying spells. 
At the age of 7 years she suffered from a mild acute glomerulonephri­
tis. At 12 years she visited the orthopedic outpatient clinic because of 
persistent low-back pain, which had started during the period of nephritic 
problems. Her complaints were interpreted as a postural problem. An 
intensive physiotherapeutic program, aimed at reinforcement of muscle 
strength, was unsuccesful. At the age of 16 years, she was admitted to the 
pediatric outpatient clinic with pronounced complaints of exercise intoleran­
ce. Normal daily activities, like riding her bicycle up the slope of a bridge 
were impaired. After a short period of effort she experienced nausea, 
dizziness and drowsiness. Physical examination showed a lean, asthenic girl 
(weight 43.4 kg; height 165 cm). The musculature was hypotonic and her 
joints were hyperelastic. Lumbar lordosis was increased. A physical exercise 
test (walking on a belt at heart rate 170 during 30 min at 5% incline) was 
completed with great effort. After the test her ability to concentrate on new 
assignments was obviously diminished. Laboratory investigation revealed no 
abnormalities, particularly muscle enzymes and lactic acid were normal. 
Electromyography showed a normal pattern. A needle biopsy of quadriceps 
femoris muscle was performed, which demonstrated nonspecific histopatho-
logical changes. 
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Personal history 
Her parents considered her as a contented child, who slept a lot and 
cried little. During feeding she frequently took short pauses. 
In early childhood she always was the first to be sent away during 
children's games in order to get some rest. At primary school she followed 
swimming lessons with a lower class, since she could not keep up with her 
own classmates. When she started to realise that her physical capacity was 
lower than that of her peers, this worried her less than the gradually 
acquired image of malingerer. 
The physiotherapeutic exercise program led to frustration about her 
physical capacities rather than to relief of the complaints of low-back pain. 
She felt that the physiotherapist and orthopaedist distrusted her willingness 
to co-operate. After the sessions she continuously dozed off during the 
following school lessons. Her peers laughed at her strange conduct, and, 
although feeling deeply ashamed, the only way to cope reasonably with the 
situation was to join their hilarity. Non-attendance of lessons and lack of 
concentration finally led to a delay in her education. Her intention to start at 
nursing school became doubtful. Leisure time was spent with physically 
non-strenuous hobbies. 
The knowledge that histopathological changes were demonstrated in her 
muscle tissue caused a sense of great relief, although no treatment could be 
offered. She finally felt her behaviour was justified. Knowing her own 
limited physical capacity, she was able to make more well-considered 
decisions concerning her future career. She chose an office job for 2 days a 
week. 
Materials and methods 
Patient muscle 
Muscle biopsies (15 needle and 2 open) were taken from the quadriceps 
femoris muscle during the first consultation. Ages of biopsy are listed in 
Table 1. After an initial screening, only those biopsies were included that 
did not show any diagnostic findings by light and electron microscopy, but 
in which abnormally large subsarcolemmal aggregates of mitochondria were 
present. 
Control muscle 
Muscle specimens (all needle biopsies) were obtained from 21 children 
and adolescents (13 males, 8 females), who were candidates for biopsy 
because of muscle hypotonia, delay in developmental milestones, mild 
neurological signs or in order to exclude skeletal muscle myopathy in the 
presence of cardiomyopathy. Their mean age was 8.1 years, ranging from 
1.2 to 20.7 years. All biopsies were taken from the quadriceps femoris 
muscle. In none of the biopsies were histopathological changes found. The 
two groups (patients and controls) were comparable with regard to age and 
sex. 
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Electron microscopy 
Muscle specimens were immediatly fixed in 2% buffered glutaraldehy-
de, postfixed in 2% buffered osmium tetroxide and embedded in Epon 812. 
Semithin sections were stained by toluidine blue. Ultrathin sections were 
contrasted with uranyl acetate and lead citrate and inspected in a Philips 300 
or 301 electron microscope (Eindhoven, The Netherlands). 
Morphometry 
Stereological analysis was performed according to Weibel (1979). Five 
randomly chosen blocks from each patient or control person were used. The 
orientation of the sections was transverse or slightly oblique with regard to 
the muscle fibre axis. Peripheral fibre areas in successive grid holes were 
photographed according to the principle of systematic random sampling. Ten 
micrographs per section and hence 50 micrographs per patient were made. 
At a final magnification of approximately 20,000x the volume density of 
peripheral mitochondria, i.e. mitochondria located within 2 μτη from the 
sarcolemma was estimated by point counting. Only points located within this 
area were counted. Volume density was thus expressed as a percentage of 
the volume of the 2 μ η thick outer layers of the muscle fibres (Elander et 
al., 1985). Number of photographs and reference space were determined in 
a pilot study. The standard error of the ratio of the means of the primary 
samples (microphotographs) was below 10% of the estimated volume 
density. 
Statistics 
To test the statistical significance of the difference between the volume 
densities of patient and control specimens, the Mest was applied. The 
relation between the different items within the patient group was investigated 
by determining the inter-item correlation coefficients. Differences between 
the incidence of the items within two groups were investigated using the 
Fisher test. The size of the patient group does not allow definite statistical 
conclusions concerning the inter-item correlations. Based on the calculated 
correlation coefficients some tendencies can be pointed out. 
Results 
Clinical and laboratory data 
The individual clinical and laboratory data are summarized in Table 1. 
Our patient group contained relatively many mentally retarded children. 
Increased serum CK level was correlated with completion of the exercise 
test (r = -0.60): patients with normal CK levels frequently failed to comple­
te the test. The results of the other clinical and laboratory tests demonstrated 
no clustering. 
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Table 2. Clinical course of exercise intolérance 
Panent No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Follow up interval (years)' 5 1 2 1 8 6 13 6 9 2 7 3 9 1 2 9 8 4 8 3 8 9 6 3 5 3 8 3 0 5 3 4 9 1 
Coune of the complaints s a d d d e d s s a a d s s s a s 
1
 time interval between first consultation and follow up interview, s, stationairy, d, decreased 
Course of the disease 
Individual data are shown in Table 2. The mean follow up interval was 
6.8 years, ranging from 0.5 to 13.6 years. None of patients experienced 
progression of the complaints. In 12 out of 17 patients the exercise intole-
rance remained unaltered during the follow-up period. In spite of a certain 
degree of adaptation to their limited physical capacity, these patients still 
were not able to function normally. The others noted improvement of their 
condition. 
Histopathological examination of muscle tissue 
In semi-thin toluidine blue stained sections increased staining intensity 
at the fibre periphery was noted in all patients (Fig. la, b). Electron 
microscopy showed an abundancy of subsarcolemmal aggregations of normal 
or slightly aberrant mitochondria in otherwise normal appearing fibres (Fig. 
1c). Ten patients showed abnormalities in cristae configuration in most of 
the subsarcolemmal mitochondria, such as zig-zag cristae (Fig. 2a) and 
honeycomb cristae (Fig. 2b). Lipid and/or glycogen depositions were 
particularly conspicuous in muscle tissue of 15 patients. Seven patients 
showed a considerable amount of lipofuscin depositions. 
Morphometric analysis of histopathological changes 
The results of morphometric analysis are shown in Table 3. Volume 
density of peripheral mitochondria was not statistically dependent on age or 
sex. Mean volume density of peripheral mitochondria was significantly 
higher in the patient than in the control group (P = 0.0001). The results of 
both groups showed an approximately Gaussian distribution (Fig. 3). 
Fig.l. (opposite page) a Control person 17: normal skeletal muscle. Toluidine blue staining, 
semithin seaion. χ 100. b Patient 13: muscle fibres with an abundancy of subsarcolemmal 
aggregations of mitochondria (large arrows), most pronounced near the capillaries (small 
arrows). Toluidine blue staining, semithin seaion. χ 90. с Subsarcolemmal aggregation of 
mitochondria. Lipofitscin deposition (L). Uranyl acetate lead citrate staining, ultrathin section, χ 
19 000. 
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Table 3. Results of morphometric analysis and ultrastructurat investigation of quadriceps muscle biopsies from patients and 
control persons 
Patient No. 1 2 3 4 5 6 7 8 9 10 U 12 13 14 15 16 17 
Morphometric analysis 
volume density' (%) 7.1 12.7 8.3 5.7 11.8 9.9 10.9 9.9 10.8 5.5 10.1 7.8 12.6 9.4 11.8 7.7 9.7 
Ultrastmctural findings 
In cytoplasm: 
increased glycogen deposition . - - + . + -
 + + 4. + - - + + + + 
increased lipid deposition + + - + + + + + + - + + - + + + + 
increased lipofuscin deposition - + - - - - + - + + + - - + + + -
In mitochondria: 
Abnormal crista configuration1 - + + + - - + + - + + - - - + + + 
Cont.pcrs.No. 
volume density1 (%) 
Mean volume density 
1 2 
3.8 4.5 
3 
4 6 
4 
9.8 
5 
3.5 
of peripheral mitoehondris 
6 
2.6 
7 
5.2 
; patients 
8 
5.4 
9.62 
9 
6.9 
10 
8.3 
± 1.69(SD) 
11 
4.9 
12 
6.2 
13 
6,4 
14 
9.0 
15 
6.8 
16 
2.7 
; controls 5.82 ± l .94(SD); Ρ 
17 
4.5 
18 
7.6 
= 0.0001 
19 
6.0 
20 
6.8 
21 
6.7 
SD Standard deviation; ' Volume density of peripheral mitochondria; 2 including zig-zag cnstae and honeycomb cristae 
ί ' * & • 
^ -
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Fig.2.a Zig-zag cristae in mitochondrion, closely associated with lipid deposition. Uranyl acetate 
lead citrate staining, ultrathin section, χ 25 500. b Honeycomb configuration of cristae. Uranyl 
acetate lead citrate staining, ultrathin section, χ 24 000. 
Relations between the course and clinical, laboratory and histopathological 
findings 
In order to detect prognostic factors the improved group was compared 
to the stationary group (Table 4). It may be noted that patients with a 
favourable course generally started out with less severe complaints (item 1) 
and showed fewer histopathological changes (item 11, 13, 14), except for 
lipid depositions, than those with a stationary course. 
Relations between quantitative histopathological changes and clinical and 
laboratory findings and course of the disease 
Patients who did not complete the exercise test had a slightly higher 
mean mitochondrial volume density (10.26 %) than patients who completed 
the test (8.4 %; P=0.18). 
In order to investigate the clinical significance of an increased volume 
density, patients with increased and normal volume densities were compared 
(upper limit of normal range= 9.6%; Table 5). Patients with a higher mean 
mitochondrial volume density did not differ significantly from those with a 
normal volume density with respect to the summarized data, but a tendency 
to a poorer exercise tolerance was noted in the former group (item 2). 
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Table 4. Incidence of clinical and laboratory findings in 
patients with a stationary and a favorable course 
Table 5. Incidence of relevant clinical and laboratory 
findings in patients with increased and normal 
volume density of peripheral mitochondna 
sUlionary 
1 Severe complaints' 
2 Ejcrcisc test uncompleted 
3 Mental retardation 
4 Motor retardation 
5 Hypotonia 
6 Muscle weakness 
7 Skeletal deformations 
8 Mild CK elevation 
9 Myopathic EMG 
10 Pennata! asphyxia 
11 Increased glycogen depositions 
12 Increased lipid depositions 
13 Increased lipofuscin depositions 
14 Volume density increased* 
(n = 12) 
10 
4(5) 
4 
6 
6 
6 
3 
5 
1(3) 
1 
9 
10 
6 
8 
favorable 
(n = 5) 
| 1 
KD 
3 
3 
4 
2 
0 
3 
2(1) 
2 
1' 
4 
1 
2 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
Severe complaints' 
Exercise test uncompleted 
Mental retardation 
Motor retardation 
Hypotonia 
Muscle weakness 
Skeletal deformations 
Mild CK elevation 
Myopathic EMG 
Perinatal asphyxia 
Increased glycogen depositions 
Increased lipid depositions 
Increased lipofuscin depositions 
Favourable course 
increased 
(n=10) 
6 
4(4) 
5 
6 
6 
6 
1 
4 
1(2) 
2 
6 
9 
5 
2 
normal 
(n = 7) 
5 
1(2) 
2 
3 
4 
2 
2 
4 
2(2) 
1 
4 
5 
2 
3 
for explanation of items see table 1, ' at first consullalion, 
1
 Ρ = 0 03 Fisher test, ' Ρ = 0 10 Fisher test * volume 
density of pcnpheral mitochondna, number of non tested 
patients in parenthesis 
for explanation of items see table 1, l at first consultation 
number of non tested patients in parenthesis 
RELATIVE FREQUENCY (%) 
2 - 4 4 6 6 8 8-10 10- 12 12 14 
VOLUME DENSITY (%) 
Fig 3 Histogram of the 
distribution of volume 
densities of peripheral 
mitochondria m patient 
and control muscle 
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Discussion 
In our study we listed the symptoms and signs of a group of patients 
with disabling exercise intolerance in whom even with muscle tissue exami-
nation a known muscle disease could not be diagnosed. Exercise intolerance 
and discomfort after exercise was the main indication for muscle biopsy 
(Dubowitz, 1985). 
The complaints usually existed several years before patients consulted a 
physician. Detailed questioning on specific topics, including the frequency of 
feeding, crying and conduct towards playmates was necessary in order to 
assess their duration and gravity. A definite pattern of clinical and laborato-
ry signs at the time of first consultation did not emerge, except for the 
observation that patients with a CK elevation more often succeeded in finis-
hing the exercise test. The conspicuously high incidence of mental retardati-
on in our patient group may be related to the myopathic disorder, since 
intellectual impairment is not infrequently noted in patients with muscular 
diseases (Dubowitz, 1978), particularly with mitochondrial myopathies 
(Lombes et al., 1989). None of the patients showed a progressive course. 
Morphometric analysis demonstrated that the muscle tissue of the 
patients had a high volume density of peripheral mitochondria in comparison 
to control tissue. We were able to delineate a group of 10 patients, whose 
volume densities exceeded the upper limit of the normal values. Clinically, 
these patients had more trouble finishing the exercise test than patients with 
a normal volume density, although the higher incidence of motor and mental 
retardation in this group may have impaired their ability to co-operate. Eight 
of ten patients with increased subsarcolemmal aggregation of mitochondria 
noted no improvement in their complaints during the follow up period. 
The significance of an increased volume density of peripheral mitochon-
dria is not understood. Increased lipofuscin depositions may indicate increa-
sed turnover of mitochondria (Sewry, 1985). Zig-zag and honeycomb 
configuration of cristae is usually noted in metabolically active tissue 
(Ghadially, 1988). An increase in the volume density of peripheral mito-
chondria in skeletal muscle is also noted after endurance training (Howald et 
al., 1985). In this case the increase correlates with an increase in aerobic 
capacity of the organism and is expressed by a greater physical performance 
capacity (Hoppeler et al., 1985). However, our patients had great difficulty 
in completing routine tasks, but their muscle tissue appeared similar to that 
of highly trained athletes. Other situations in which peripheral mitochondria 
exhibit a presumably compensatory growth are peripheral vascular occlusive 
disease (Änquist and Sjöström, 1980; Bylund-Fellenius et al., 1981; Dubo-
witz, 1985) and partial cytochrome oxidase deficiency (Chung and Nonaka, 
1988). 
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We suggest that the extensive accumulation of peripheral mitochondria 
is the morphological expression of a compensatory reaction to an unknown 
Pertubation of energy metabolism, although biochemical investigation of the 
metabolic pathways in muscle tissue from two of our patients revealed no 
abnormalities in mitochondrial function (unpublished results). Possibly the 
cause of the disease is located outside the mitochondrion (e.g. oxygen 
supply or energy transport between mitochondria and myofibrils). 
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SECTION II 
Experimental approach 

CHAPTER 5 
Fatigue and muscle adaptation 
Introduction to experimental approach 
Although the patients presented in Chapters 2 and 3, suffering from the 
Nijmegen syndrome, and the patients presented in Chapter 4, with exercise 
intolerance and miscellaneous other symptoms (henceforth referred to as 
EIMOS patients), can be distinguished on both clinical and histopathological 
grounds (Table 1), they have some important features in common. Both 
categories of patients are characterized by a disabling fatigability which 
prevents performance of normal daily activities, and which does not decrea-
se after training programs. Also, an increased content of mitochondria 
(increased volume density) in skeletal muscle is noted in both categories. 
Skeletal muscle tissue is known to be capable of adapting structurally 
and functionally to the demands placed upon it. An increase in the volume 
density of mitochondria is noted under several physiological and pathophysi-
ological conditions. Regardless of the cause, the increase invariably appears 
to result in a delay in the onset of fatigue by assuring the required energy 
production. 
The possibility is considered that the increase in the amount of mito-
chondria in the skeletal muscle tissue of our patients represents a defense 
mechanism against an unknown pathophysiological condition which causes 
increased fatigability. Taking into account the fact that the functioning of 
mitochondria in vitro does not correlate with the clinical signs, attention was 
focussed on conditions outside the mitochondrion which may cause impaired 
energy production. In the following chapter the concept of fatigue is 
discussed and then the relationship between fatigability and the volume 
density of mitochondria is described. Impaired oxygen delivery as one of the 
extra-mitochondrial conditions which may cause both increased fatigability 
and increased mitochondrial content, is discussed in relation to the findings 
in the patients. Finally, an experimental model is presented intended to test 
the hypothesis that impaired oxygen delivery is involved in the EIMOS 
patients. 
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Table 1 Summary of the main clinical, labo ralo ry and histopalholugical 
features of the Nijmegen syndrome and EIMOS patients 
Clinical findmes 
Heredity 
Onset 
Cataract 
Increased fatigability 
Course 
Cardiac involvement 
CNS1 involvement 
Laboratory findings 
Lactic acidosis 
Histopatholoeical Cindines 
in skeletal muscle tissue 
Routine examination 
Mitochondnal structure 
Volume density of peripheral 
mitochondna 
Nijmegen syndrome 
autosomal recessive 
congenital 
yes 
yes 
fatal 
yes 
no 
yes 
unremarkable 
sevcrly damaged 
increased 
EIMOS patienta 
no heredity 
congenital or later 
no 
yes 
stationary or favorable 
no 
maybe 
no 
unremarkable 
incidental mild alterations 
increased 
1
 Central Nervous System 
Fatigue 
Muscle fatigue may be defined as the loss of the ability to generate 
force. Considering individuals as wholes rather than as made up of isolated 
muscles, central factors which limit physical exercise as well as peripheral 
factors concerning muscle fibres must be taken into account. All voluntary 
movement is under the control of the central nervous system, and informati-
on must be conducted adequately from the cerebral cortex to the neuromus-
cular junction and the sarcolemma. The sense of effort and discomfort 
during exercise, whatever factor(s) cause these cortical perceptions, might 
limit the will to continue exercise. If fatigue is caused by a disturbance in 
the efferent or afferent part of the nervous system it may be defined as 
central fatigue (Roberts and Smith, 1989). 
Factors occurring distally from the neuromuscular junction are involved 
in the development of so-called peripheral fatigue. These factors include 
energy supply (ATP, creatine phosphate, glycogen, oxygen, free fatty acids) 
and the accumulation of metabolites (lactate, hydrogen ions, calcium, 
ammonium, electrolyte and water shifts; for a review see Booth and Thoma-
son, 1991). 
We assume that the fatigue in both our patient groups is of the periphe-
ral type, i.e. caused by a mechanism acting within the muscle tissue. Some 
caution must be taken when considering the EIMOS patients, since the 
relatively high incidence of mild mental retardation indicates that fatigue 
may be of a central origin. However, the presence of alterations in skeletal 
muscle and the lack of a correlation between the volume density of mito-
chondria and the occurrence of mental retardation (i.e. mentally retarded 
patients are not characterized by a lower volume density of mitochondria 
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than the rest of the group) justify the assumption that these patients also 
suffer from peripheral fatigue. 
Fatigue and volume density of mitochondria 
Under physiological conditions fatigability of skeletal muscle is related 
to the volume density of mitochondria in the muscle, i.e. the higher the 
volume density, the less the fatigability (Hoppeler et al, 1985). The 
oxidative capacity of a muscle is in direct proportion to the quantity of 
mitochondria in this muscle (Schwerzmann et al., 1989). A number of 
stimuli have been reported to induce an increase in skeletal muscle mito-
chondria: exercise (Hoppeler et al., 1985); electrical stimulation (Hoppeler 
et al, 1987); and hypoxia (Holm et ai, 1973; Blander et al., 1985; Yoshino 
et ai, 1990). 
In the case of exercise, the adaptive increase in the mitochondrial 
volume density occurs concomitantly with an increase in the capillary supply 
to muscle fibres and an increase in muscle myoglobin concentration (Patten-
gale and Holloszy, 1967; Wittenberg, 1970). These three adaptations 
probably function synergistically to account for the increase in Vo2max 
(maximal oxygen consumption). The increase in Vo2max makes it possible 
for individuals to exercise at higher work rates when they are trained than 
when they are untrained. Furthermore, as a consequence of the increase in 
skeletal muscle oxidative capacity, which corresponds to the mitochondrial 
volume density (Hoppeler et al. 1987; Schwerzmann et al., 1989), submaxi-
mal exercise results in less disturbance in homeostasis in the trained than in 
the untrained state, as reflected by less lactate accumulation and glycogen 
depletion. As a result, individuals are able to work at a higher percentage of 
their maximum capacity, and fatigability is less in trained than in untrained 
muscles (for a review see Booth and Thomason, 1991). 
Hypoxia caused by impaired blood flow to muscle (referred to as 
ischemia), occurs in patients with peripheral occlusive arterial disease 
(Ängquist and Sjöström, 1980; Bylund-Fellenius et al., 1981; Jansson et al., 
1988). In such cases the increase in the volume density of mitochondria will 
probably not contribute to an increase in Vo,max. In ischemia Vo2max is 
limited by blood supply rather than by the quantity of oxidative enzymes. 
The main advantage of an increase in the volume density of mitochondria 
appears to be an increase in the extraction of oxygen from the capillaries 
due to an increased Po, gradient from the capillary to the perimitochondrial 
area. An increase in the volume density of mitochondria in hypoperfused 
skeletal muscle leads to decreased fatigability of muscle (Erney et al., 
1991). An increase in the activity of several mitochondrial enzymes was also 
demonstrated after hypoxic hypoxia (reduction of oxygen content in inspired 
gas mixture; Holm et ai, 1973; Yoshino et ai, 1990). 
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It was suggested that a component in the perturbation of cellular 
homeostasis (whether caused by increased demand or by impaired producti-
on of ATP) signalling the need for an increase in the rate of ATP synthesis 
might also induce the adaptive increase in mitochondria (Ohira et al., 1987). 
The underlying response all these stimuli have in common is a decrease in 
high-energy phosphates (i.e. ATP and phospho-creatine) and an increase in 
ADP, P, and creatine concentrations. Moreover, deficient ATP production 
by aerobic metabolism will be compensated for by anaerobic ATP producti-
on, causing an accumulation of lactic acid. All these factors may contribute 
to the development of fatigue. A higher mitochondrial content results in a 
smaller disruption of these concentrations from their homeostatic levels 
(Constable et al., 1987; Dudley et ai, 1987), and might thus be considered 
as an effective means of combatting fatigue. 
We will now consider the possibility that impaired oxygen delivery to 
mitochondria is a pathogenetic factor in the investigated patients. 
Nijmegen syndrome patients 
In these patients, the increase in the volume density of mitochondria 
probably does not correlate to an increased oxidative capacity, since the 
surface area of inner mitochondrial membrane is severly diminished. 
Proliferation of structurally abnormal mitochondria is a common sign in 
mitochondrial myopathies. It is generally considered to represent a futile 
attempt by muscle fibre to compensate for a reduced oxidative capacity due 
to a deficiency in mitochondrial metabolism. However, despite the severly 
damaged ultrastructure of the mitochondria and the clinical signs of distur-
bed energy production in our patients, the mitochondrial function in vitro 
appeared to be within normal ranges. Considering the possibility of an extra-
mitochondrial lesion causing both impaired energy production and increased 
mitochondrial content, some clinical features deserve attention. It is remar-
kable, especially in patients with the fatal neonatal form, that the clinical 
picture is dramatic and fatal shortly after birth, whereas during gestation or 
at delivery no signs of fetal distress are noted. One of the major metabolic 
changes in skeletal muscle in the perinatal period is a sharp rise in oxidative 
metabolism as soon as the neonate starts to breath (Towell et al, 1985). 
Defense mechanisms against cellular hypoxia which appear to exist during 
fetal life disappear during the first days of life (Jöbsis van der Vliet, 1992). 
Eye lenses are only vascularized during the first 5 months of gestation, are 
very sensitive to oxygen deficiency, and react by forming cataracts when 
oxygenation is disturbed (Varma et ai, 1984). These findings support the 
view that oxygen deficiency may be involved in the pathogenesis of the 
Nijmegen syndrome. This was also suggested by Smeitink et al. (1989). 
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No indications were found in the literature that oxygen deficiency can 
cause the severe histopathological changes observed in these patients, unless 
the oxygen supply is so low that the viability of the tissue is seriously 
threatened. It should be noted, however, that the experimental approach is 
limited to two kinds of manipulation of oxygen supply, i.e. hypoxic and 
ischemic hypoxia. These experimental procedures might have other effects 
on muscle tissue structure than possible pathologic conditions of oxygen 
deficiency, e.g. diffusion limitation by myoglobinopathy or alterations in 
capillary endothelium. Moreover, oxygen deficiency during gestation and/or 
in the perinatal period may also have its own specific impact. Due to 
practical limitations, this option was not investigated. The patients will be 
further discussed in Chapter 7. 
EIMOS patients 
In contrast with the Nijmegen syndrome patients, in EIMOS patients 
heredity is not a factor and they cannot be considered as a clinical entity. 
They show alterations in skeletal muscle which appear to be adaptive rather 
than pathologic. The increase in content of normal-appearing mitochondria 
in skeletal muscle may be an adaptive response to an unknown pathogenetic 
factor which also causes clinical signs of increased fatigability, and its 
purpose might be to combat fatigability. Since hypoxia might cause increases 
in both fatigability and volume density of skeletal muscle mitochondria, it 
was hypothesized that an impairment in oxygen transport to mitochondria is 
a pathogenetic factor. Clinical and laboratory investigation did not reveal 
any signs of cardiovascular, respiratory or hematological disease. This 
suggested that the possible impairment in oxygen delivery was located 
within the muscle tissue itself. Such a disturbance cannot be detected 
clinically, although a decrease in muscle oxygen consumption can possibly 
be traced by measuring the difference in oxygen content of arterial and 
venous blood. For ethical reasons such measurements were not planned until 
more evidence to support the hypothesis was obtained. 
To illustrate the resistances that oxygen experiences on its pathway to 
the mitochondria, the transport of oxygen in skeletal muscle tissue is briefly 
discussed. 
Delivering oxygen to mitochondria, based on a review by Kreuzer et al. 
(1991) 
Oxygen delivery to skeletal muscle can be tentatively separated into 
oxygen supply and oxygen diffusion. Oxygen supply is represented by the 
blood flow through the muscle. This is dependent on capillary distribution 
and the degree of homogeneity of flow through the capillaries. Oxygen 
diffusion occurs along a Po2 gradient from the erythrocyte to the perimito-
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chondrial afea. This is dependent on the composition and chemicophysical 
properties of capillary blood, the structure and components of the tissues 
between the erythrocyte and the mitochondrion, and the oxygen consumption 
of the mitochondria. Results of investigations about which of these two, i.e. 
supply or diffusion, mainly limits oxygen delivery are conflicting. However, 
some predictions can be made based on theoretical calculations about factors 
affecting supply and diffusion. 
The experimental approach to the area where oxygen is transferred 
from the blood to the mitochondria is problematic. Although the micro­
anatomy can be described in great detail, in vivo investigation of the actual 
flow of oxygen through the different types of tissues, as represented by local 
oxygen partial pressures, requires disturbance of the microenvironment and 
activates autoregulatory mechanisms which might greatly alter the pre­
existing situation. 
Until now, the two most extensively-used methods of investigation have 
been the Polarographie determination of tissue Vo2 and the cryomicrospec-
trophotometric determination of local myoglobin saturation. Use of the 
Polarographie needle or the surface electrode requires either penetration of 
the muscle or surgical exposure of its surface, respectively. The outcome of 
the measurements is a result of the interference between the Po2 field in the 
manipulated tissue and the diffusion field of the electrode, which itself 
consumes oxygen. The cumulated Po2 values, measured at several locations 
in or on the muscle, give an impression of the oxygen partial pressure 
within muscle tissue as a whole. A greater resolution (up to 4 μπι) can be 
derived by calculation of Po2 from the saturation of myoglobin locally 
measured on frozen sections by means of cryomicrospectrophotometry. The 
muscle tissue must be frozen immediately after surgical exposure in order to 
produce the fewest artefacts. Honig et al. (1984) and Gayeski and Honig 
(1991) demonstrated the absence of strong Po2 gradients within muscle 
fibres, which was ascribed to the additional diffusion of oxygen by myoglo­
bin. Another consequence of this finding is that a considerable Po2 gradient 
must exist within or close to the capillary (capillary barrier), which was a 
new point of view in theoretical considerations on muscle oxygenation. A 
recent review of methods of measurement is presented by Vanderkooi et al. 
(1991). 
While considering oxygen supply to mitochondria, a model should be 
provided in which the influence of numerous factors which might affect 
oxygen supply can be introduced, in order to calculate the effect of these 
factors on oxygen delivery. The classical theoretical approach, which was 
developed long before experimental results could be obtained, is due to 
Krogh (1919) and his mathematician Erlang, with their model of a tissue 
cylinder around a central capillary running parallel to the resting muscle 
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fibre, assuming no oxygen flux at the periphery. Despite the numerous 
assumptions in this model, it is still a valuable approach to the general 
properties of oxygen transport. The discussion of factors influencing oxygen 
delivery in the following text is based on the calculations used in the Krogh 
model. 
Within the capillary the main determinant of the rate of oxygen diffusi-
on into the tissue is the Po2 (partial oxygen pressure), which is dependent on 
the saturation of hemoglobin and the properties of the oxygen dissociation 
curve, which alter from the arterial beginning to the venous end of the 
capillary. It is widely accepted that the erythrocyte membrane and the 
capillary wall do not offer extra resistance to oxygen diffusion. Oxygen 
leaving the erythrocyte will either come into contact with endothelium 
almost immediately, or it may enter the plasma gap between erythrocytes, 
the width of which may influence oxygen transfer. Until recently the 
resistance to oxygen diffusion within the interval from hemoglobin to 
sarcolemma was considered to be of minor importance. The suggestion of a 
strong Po2 gradient in this region (Honig et al., 1984) necessitates a reconsi-
deration of the point of view that the capillary part of the pathway for 
oxygen does not contain a significant resistance. 
The conditions of diffusion within myocytes are represented in the 
Krogh-Erlang equation by the Krogh coefficient K, which is assumed to be 
homogenous and isotropic. However, the effective value may be influenced 
by several factors, and local differences according to the structure and 
components of the tissue are to be expected. Again, too little is known about 
the actual in vivo value of the permeability of oxygen within skeletal muscle 
tissue. The effect of facilitation of oxygen diffusion by myoglobin can be a 
flattening of the Po2 profile, which means that the tissue Po2 is raised 
particularly in the deeper parts of the muscle fibre at the venous end of the 
capillary. 
Capillaries in skeletal muscle are predominantly orientated along the 
muscle fibres with occasional transverse connections. The distribution of the 
capillaries amongst the myofibres as observed in a transverse section of 
skeletal muscle is not geometrically regular (Eggington et al., 1988). Fibres 
with high oxidative potential are usually surrounded by more capillaries than 
fibres with a lower oxidative potential (Gray and Renkin, 1978). Capillary 
blood flow is intermittent while all or only some capillaries may be perfused 
at rest. Turek et al. (1991) showed by simulating Po2 histograms from both 
Polarographie measusurements and myoglobin cryospectrophotometry, that 
tissue oxygenation is dependent on the geometrical heterogeneity of the 
capillary network and on the type of blood flow through capillaries, unless a 
high capillary barrier together with Po2-dependent and varying oxygen 
consumption is postulated. The view that heterogeneity in capillary spacing, 
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resulting in diffusion inhomogeneity, plays an important role in tissue Po2 
has also recently been supported by others (Piiper and Scheid, 1991). 
A parameter related to capillary distribution is the distribution of 
skeletal muscle mitochondria, which occur in higher density near capillaries 
(Kayar and Banchero, 1987). This results in a flattened Po2 profile that 
penetrates deeper into the cell. Mainwood and Rakusan (1982) showed that 
clustering of mitochondria near capillaries sharply diminishes R (i.e. the 
radius of the tissue cylinder in the Krogh-Erlang equation), which accordin-
gly decreases the required Po2 gradient. However, this view is opposed by 
Jones (1986), who suggests that mitochondrial clustering leads to a decrease 
in oxygen permeability. 
Other factors affecting oxygen supply are perfusion inhomogeneities of 
the capillary network, capillary transit time of erythrocytes, arteriovenous 
shunting and capillary hematocrit. Also, all the above-mentioned parameters 
are affected by the sympathetic nervous system as well as by vasodilating 
metabolites. 
The second determinant of oxygen flow is the rate at which mitochon-
dria consume oxygen. This rate may vary manifold, depending on the state 
of activity of the muscle. In well-stirred mitochondrial suspensions, the Km 
of cytochrome oxidase (the terminal enzyme of the respiratory chain) was 
shown to be very low (in the order of 0.05 mmHg; Starlinger and Lubbers, 
1972), which means that the reaction rate of cytochrome oxidase would not 
be oxygen-dependent under physiological conditions. However, experiments 
with immobilized enzymes have shown an oxygen-dependent reaction rate of 
this enzyme (Engasser, 1978), and the rate of mitochondrial oxidative 
phosphorylation in vivo appears to be dependent on oxygen pressures within 
the physiological ranges (Harrison et al., 1990; Wilson, 1990). 
It appears that flow autoregulation, leading to a redistribution of 
capillary flow and the achievement of a more uniform Po2 is one of the 
major factors preventing the perimitochondrial Po2 from falling below levels 
at which cytochrome oxidase becomes oxygen-dependent. 
Experimental approach 
The intention was to investigate whether any impairment in the above-
mentioned transfer of oxygen from blood to mitochondria would cause 
alterations in the mitochondrial population observed in the EIMOS patients. 
Rats were exposed to hypoxic hypoxia (Fi02 = 0.08; normal 0.21) for 
several weeks. This grade of hypoxia, combined with mild exercise, causes 
alterations in the redox state of cytochrome oxidase (Piantadosi et al., 
1986), and an elevation of the NADH/NAD+ ratio (Katz and Sahlin, 1987), 
which indicates that the amount of oxygen reaching the mitochondria is 
deficient. The experiment is described in Chapter 6. 
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CHAPTER 6 
Changes in volume densities and distribution of 
mitochondria in rat skeletal muscle after chronic 
hypoxia' 
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Summary 
In order to test the hypothesis that subsarcolemmal aggregation of 
skeletal muscle mitochondria, as noted in some patients with mitochondrial 
myopathies, is caused by an impaired oxygen supply to mitochondria, we 
exposed 2 groups of rats to 8% 02 during 44 or 45 days. One group 
performed mild exercise, as did a normoxic control group. After hypoxia we 
investigated fibre type composition, fibre diameter and capillarity of soleus 
and extensor digitorum longus (e.d.l.) muscles. Mitochondrial volume 
densities were determined by morphometric analysis. 
In both e.d.l. and soleus muscle fibre type composition was unchanged 
and fibre diameter was reduced after hypoxia. Capillary network was 
unchanged, hence capillary density was increased in both muscles after 
hypoxia (p < 0.05 in untrained soleus). 
Total mitochondrial volume density was increased in soleus muscle, 
which was due to an increase in the volume density of intermyofibriliar 
mitochondria (p < 0.05 in the trained group), whereas the volume density 
of subsarcolemmal mitochondria decreased. In e.d.l. muscle the volume 
density of both intermyofibriliar and subsarcolemmal mitochondria decrea-
sed. 
We conclude that subsarcolemmal aggregation of mitochondria did not 
occur after chronic hypoxia. In soleus and e.d.l. muscle different changes in 
' International Journal of Experimental Pathology (1992) 73:51-60 (modified version) 
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the volume densities of mitochondria occurred. This may be related to the 
relative amounts of type I and type Π fibres within these muscles. 
Introduction 
Mitochondrial myopathies (MM's) can be divided into: 1. primary 
MM's, in which the cause for the clinical and histopathological abnormali­
ties is situated within the mitochondrion itself (e.g. enzyme defects in 
Kreb's cycle or respiratory chain, 2. secondary MM's, in which the mito­
chondrial abnormalities are the consequence of an extra-mitochondrial 
influence (e.g. hypothyroidism, steroid myopathy), and 3. MM's of 
unknown cause, in which no enzyme defect or extra-mitochondrial lesion 
can be demonstrated. 
Histopathologic changes in the patients of the latter group may concern 
only subtle alterations in the mitochondrial population, which are confined to 
subsarcolemmal aggregations (Van Ekeren et al., 1991), without demonstra­
ting overt damage to the mitochondria themselves. It is a well known 
characteristic of mitochondria to aggregate at the fibre periphery during 
ischemia, caused by arterial ligation (Heffher and Barron, 1978) or arterial 
insufficiency (Blander et al., 1985), However, it is largely unknown 
whether an altered mitochondrial distribution may also be caused by a 
chronic impairment of oxygen supply to mitochondria. Such impairment, 
which would cause clinical signs of exercise intolerance and fatigability, 
may be localized somewhere between hemoglobin in tissue capillaries and 
skeletal muscle mitochondria. Recently, abnormalities of structures essential 
for oxygen supply, e.g. microvessels (Sakuta and Nonaka, 1989) and 
myoglobin (Kawai et al., 1991), were demonstrated in neuromuscular 
diseases. 
It was our goal to investigate whether chronic hypoxia causes alterati­
ons in the mitochondrial population of rat skeletal muscle tissue. Capillariza-
tion, which is related to mitochondrial distribution (Kayar and Banchero, 
1987), was also investigated. Hypoxia was attained by maintaining rats at 
Fi02 = 0.08 (fraction of oxygen in inspired gas mixture). Since structural 
alterations at the tissue level are unlikely to occur without an extra challenge 
to the oxidative metabolism (Banchero et al., 1985), some of the hypoxic 
rats performed mild exercise. After 44 or 45 days we examined soleus and 
extensor digitorum longus (e.d.l.) muscle and determined quantitative 
differences by morphometric analysis. The soleus muscle is predominantly 
composed of type I fibres (approximately 87%), whereas in e.d.l. muscle 
the majority of the fibres belongs to the type II class (approximately 98%; 
Armstrong and Phelps, 1984). This implicates that soleus muscle is more 
dependent on oxygen for energy generation than e.d.l. muscle. 
62 
Materials and methods 
Eighteen 7-week-old female Wistar rats were randomly divided in three 
groups, and housed in standard plastic rat cages (3 rats/cage). Animals were 
fed rat chow and water ad libidum and were maintained at a 12-h light/12-h 
dark photoperiod. Hematocrit values were determined at day 0 and day 
44/45. 
Group 1 was the normoxic control group. The cages of groups 2 and 3 
were installed in a hypoxic device (see below) placed in the same room as 
group 1. Two identical walking belts were used, one of which was located 
in the device. 
From day 0 to day 7 the oxygen concentration within the hypoxic 
device was gradually lowered from 21% to 8%. At the second day a daily 
exercise program started for groups 1 and 2, involving 30 minutes of 
running at 15 metres/minute, 0" incline, representing approximately 60% of 
Лептах (Fregosi and Dempsey, 1984) for 6 days/week. Group 3 remained 
sedentary. 
Between the 40"' and 44lh day 2 and 3 rats of groups 2 and 3 respective­
ly died with signs of right heart failure and pulmonary congestion. At day 
44 or 45 the remaining animals were anaesthesized with Narcovet (Aphar-
mo, Arnhem, The Netherlands) 55 mg/kg body weight intraperitoneal. The 
soleus muscle and the extensor digitorum longus muscle were excised and 
processed as described below. The animals were killed by an intracardial 
injection with Narcovet . 
Hypoxic device 
A PVC isolator was adapted for use as a hypoxic device according to 
Winter et al. (1985). The hypoxic device was placed in an air-conditioned 
room in which the temperature was maintained between 20 and 22 °C. 
Oxygen concentration was regulated by adding pure (100%) nitrogen to a 
closed gas circuit and monitored by a Teledyne TED 100 oxygen analyser 
(Teledyne Electronic Devices, California, USA), which could be preset to 
any desired value. The oxygen sensor was checked and, if necessary, 
calibrated daily by exposing it to room air and 100% nitrogen. 
The hypoxic environment was totally isolated from room air during the 
whole experiment. Cleaning and nourishing materials were moved through 
an air-lock, which did not appreciably influence oxygen concentration. 
Tissue processing. 
Immediately after excision the muscles were cut into two parts. The 
proximal part was cut into slices of approximately 1 mm thickness and 
immersed in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer with 
4% sucrose, pH 7.4, osmolarity 556 mosmols. The samples were postfixed 
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in 2% osmium tetroxide, dehydrated and embedded in Epon 812. Ultrathin 
sections were cut on a Reichert microtome (Germany) and contrasted with 
lead citrate and uranyl acetate. The distal part was frozen in isopentane 
cooled in liquid nitrogen. Cryostat sections (10 μτή) were stained for 
alkaline phosphatase and counterstained with haematoxilin, and also for 
ATPase at preincubation pH 4.6 and for SDH. 
Light microscopy 
Fibre typing was performed by projecting ATPase stained sections 
through the whole muscle belly on a white tablet at a final magnification of 
180 x. Type I and II fibres were counted in randomly chosen, non-overlap­
ping fields until a total of 500 fibres was reached. SDH staining did not 
permit discrimination between type IIA and IIB fibres (see Results). 
Area (Α[ί]), diameter (D[f]) and number (NffJ) of fibre profiles were 
determined by projecting alkaline phosphatase/hematoxilin stained sections 
on the digitizer tablet of a MOP Videoplan measuring instrument (Kontron, 
Germany) with a Zeiss microscope, equipped with a prismatic lens. Measu­
ring area was determined by outlining that part of the visual field in which 
only transversely cut, complete fibre profiles were observed. Fibre profiles 
were outlined and the number of fibres counted. In cases of ellipsoid 
profiles the lesser diameter was considered to be the profile diameter. 
Before measurement of each section, the exact magnification deduced from a 
projected micrometer was introduced in the Videoplan software. Magnificati­
on varied between 436x and 443x. 
Capillaries situated in the immediate environment of one fibre were 
counted to determine the number of capillaries per fibre (CAF). The number 
of capillaries at the outer border of the measuring area (N[co]) and in 
between the myofibres (N[ci]) was counted. The same procedure was carried 
out in 3 to 6 adjacent, non-overlapping visual fields until approximately 250 
fibres and adjacent capillaries were counted in each muscle sample. 
With these data we calculated the capillary-to-fibre ratio, i.e. the ratio 
between the total number of capillaries and the total number of fibre 
profiles, and the capillary density, i.e. the number of capillaries per mm2 
muscle tissue according to the next formulas: 
capillary-to-fibre ratio: NN[c,fl = (N[ci]-l-1/2N[co])/N[fl 
capillary density: NA[c,f]=(N[ci]-l-^N[co])/(N[flx^,/2D[f])2) 
N[co] is halved to compensate for the fact that these capillaries also supply 
fibres outside the measuring area (Pietschmann et al., 1982). 
Electron microscopy 
Sampling of muscle tissue and morphometric analysis was performed 
according to Weibel (1979). Five ultrathin sections per muscle were cut 
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transversely or nearly transversely with regard to the muscle fibre axis, 
which is appropriate for estimation of the volume density of mitochondria. 
Ten microphotographs were made by systematic random sampling from each 
section. Diapositives were projected on a transparent screen fitted with a 
square lattice having a line spacing of 15 mm. Calibration was performed 
using a grating replica. Final magnification was approximately 22,000x. 
The points which laid over subsarcolemmal mitochondria, intermyofib-
rillar mitochondria, myofibrils and remaining structures were separately 
counted. Subsarcolemmal mitochondria were defined as those mitochondria 
which did not have myofibrils interposed between them and the sarcolemma. 
All other mitochondria were intermyofibrillar. Only points within the muscle 
fibres were counted, thus creating a reference space which consists of the 
total muscle fibre volume. The following parameters were calculated 
(Weibel, 1979): 
volume density of: 
subsarcolemmal mitochondria: Vv[ms,f| 
intermyofibrillar mitochondria: Vv[mi,f] 
total mitochondria: Vv[mt,f] 
myofibrils: Vv[mf,f| 
The Standard Error of the Ratio (SER) of the means of the primary samples 
(micrographs) from each muscle was below 10% of the estimated volume 
density, except in the case of Vv[ms,f], which showed a higher SER due to 
the spatial heterogeneity of the subsarcolemmal mitochondria (Eisenberg et 
al., 1984). 
Statistics 
For statistical analysis of group means the two-tailed Student's Mest 
was used. 
Results 
Physiological data 
The gain of bodyweight was slower in the hypoxic groups (Table 1). At 
day 44/45 both hypoxic groups showed lower mean body weight than the 
normoxic group, which was statistically significant in the untrained hypoxic 
group. Hematocrit values were significantly increased in both hypoxic 
groups with regard to the normoxic group (Table 1). 
Post mortem examination of prematurely deceased animals 
Body weight of these animals was in the same range as of the surviving 
animals, belonging to the same group. The hearts were rounded and hyper-
trophied. The lungs as well as the other internal organs were severely 
hyperemic and intrapleural hemorrhagia was noted. 
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Table 1 Body weight and haematocnl values of rats subjected to norm-
oxiaand training (group 1, n= 6), hypoxia and training (group 
2, η = 4) and hypoxia (group 3, η = 3) Values are means ± 
standard deviation 
group 1 group 2 group 3 
bodvweieht (g) 
dayO 116 ± 7 118 ± 14 108 ± 6 
day 44/45 206 ± 9 187 ± 15 174» ± 13 
hematocrit (%) 
day 0 43 ± 2 44 ± 2 45 ± 1 
day 44/45 47 ± 2 80* ± 2 80· ± 2 
* ρ < 0 05 m comparison to normoxic group 
Morphological data 
In both soleus and e.d.l. muscle, enzymehistochemistry revealed no 
difference in the fibre type distribution in the three groups (Table 2). A 
wide spectrum of SDH activity was noted both in fibres of hypoxic and 
normoxic animals, which permitted no discrimination between type IIA and 
IIB fibres. Fibre atrophy was not noted. The microvasculature of the 
hypoxic animals was partly distended and crowded with erythrocytes. 
Electronmicroscopy revealed no ultrastructural changes in the muscle fibre 
organelles in both hypoxic groups. Mitochondrial ultrastructure per se was 
unaltered, and the structure and amount of cristae appeared normal. Only in 
the soleus muscle, screening of a large series of micrographs suggested a 
difference between the hypoxic groups and the normoxic group in the 
quantity of intermyofibrillar mitochondria (Fig. l.a and b.). 
Table 2 
type I 
Percentage of type I fibres in soleus and e d 1 
soleus muscle 
group 1 group 2 
83 ± 6 83 ± 4 
group 3 
81 ± 7 
muscle (means ± standard deviation) 
e d 1 muscle 
group 1 group 2 
4 ± 4 5 ± 3 
group 3 
3 ± 1 
for group characteristics see table 1 
Table 3 Fibre si/e and capillanzatioη of soleus and e d 1 muscle (means ± standard déviation) 
soleus muscle e d 1 muscle 
group 1 group 2 group 3 group 1 group 2 group 3 
fibre diameter (μπι) 45 4 ± 1 4 41 6 ± 3 9 40 0 ± 5 1* 43 5 ± 4 5 37 7 ± 3 9* 37 8 ± 4 2* 
CAF 5 3 ± 0 4 5 0 ± 0 6 4 8 ± 0 5 3 7 ± 0 4 3 5 ± 0 2 3 6 ± 0 2 
NN(c,n 2 0 ± 0 2 1 9 ± 0 3 1 8 ± 0 3 1 3 ± 0 1 1 2 ± 0 1 1 2 ± 0 1 
NJc.n (mm7) 1251 ± 79 1402 ± 81 1459 ± 157** 851 ± 133 1067 ± 222 1072 ± 222 
for group characlenslics see table 1, * ρ < 0 10 in companson with the same muscle in normoxic group, 
** ρ < 0 05 ш companson with soleus of normoxic group 
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Fig.l. a Soleus muscle of normoxic rat. Mitochondria indicated by arrows. Uranyl acetate lead 
citrate staining, ultrathin section, χ 11 500 b. Soleus muscle of hypoxic trained rat. Mitochondria 
(arrows) are larger and appear more frequently between the myofibrils than in Fig. l.a. Uranyl 
acetate lead citrate staining, ultrathin section, χ II 500 
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Fig.2 Nearly transverse sections, used for morphometric analysis. Since the appearance of 
mitochondria (arrows) in skeletal muscle tissue is dependent on the level of sectioning, morphome­
tric analysis was applied to confirm the observed difference, a Soleus muscle of normoxic rat. 
Uranyl acetate lead citrate staining, χ 9100. b Soleus muscle of hypoxic trained rat. Mitochondria 
appear larger than in Fig 2.a. Uranyl acetate lead citrate staining, χ 9100. 
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Morphometric data 
Table 3 summarizes the data on fibre size and capillarity. Mean fibre 
diameter of both muscles was smaller in both hypoxic groups. The decrease 
was statistically significant in soleus muscle of untrained hypoxic animals. 
Capillary-to-fibre ratio and number of capillaries per fibre were unchanged 
in both muscles after exposure to hypoxia. Consequently the capillary 
density, i.e. the number of capillaries per unit area of muscle fibre, increa­
sed in both hypoxic groups and in both muscles due to the smaller fibre 
diameters; in the soleus muscle of untrained hypoxic animals the increase 
was statistically significant. 
In soleus muscle the volume density of intermyofibrillar mitochondria 
was increased in both hypoxic groups with regard to the normoxic group 
(Fig. 2.a and b.); it was statistically significant only in the untrained group. 
The volume density of subsarcolemmal mitochondria was reduced in both 
groups (Table 4; Fig. 3.a). These alterations resulted in a rise of the volume 
density of total mitochondria in both hypoxic situations in soleus muscle, 
although not statistically significant. 
In contrast to the soleus muscle, the e.d.l. muscle showed a decrease in 
volume densities of intermyofibrillar and of subsarcolemmal mitochondria, 
which was most pronounced after hypoxia without training (Table 4; Fig. 
3.b). 
In both muscles and in both hypoxic groups the volume density of 
myofibrils was slightly increased after hypoxia. 
Table 4 
V
v
[mi,n 
V
v
[ms,n 
V
v
|ml,n 
V
v
lmf,n 
Ultrastructural composition of soleus and с 
soleus muscle 
group 1 group 2 group 3 
6.2 ± 0 3 7 3 ± 0 7* 6.9 ± 0 9 
2.2 ± 1.0 1 8 ± 0 7 1.9 ± 1.0 
8.4 ± 0.8 9.0 ± 1.2 8.8 ± 1.8 
80.2 ± 2.8 82.6 ± 4.9 84.4 ± 0 5 
d 1 muscle (means ± standard deviation) 
e d.i. muscle 
group 1 group 2 group 3 
5.4 ± 1 3 5.0 ± 1.7 4.7 ± 1.0 
2 1 ± 1 0 1.9 ± 0 7 1.3 ± 0.2 
7 5 + 1 3 6.9 + 2 0 6 1 + 1 1 
81.0 ± 4.4 82.9 ± 2.2 82 5 ± 2 1 
for group characteristics see table I; · ρ < 0 05 in comparison with soleus of лоптюхіс group 
Fig.J Means of mitochondrial 
volume densities in normoxic 
(n = 6), hypoxic trained (n = 4) 
and hypoxic (n = 3) rats of: 
a soleus muscle, and: Ь extensor 
digitorum longus muscle. 
m intermyofibnllar 
^subsarcolemmal 
normoxia 
training 
hypoxia 
training 
hypoxia 
• • « 1 0 1 2 
volume density (%) 
normoxia + 
training 
hypoxia + 
training 
hypoxia 
b 
ш intermyofibnllar 
за subsarcolemmal 
• 4 1 1 ) 0 t t 
volume density (%) 
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Discussion 
It has been proposed previously that the mitochondrial distribution in 
muscle represents a balance of distances for the transfer of oxygen and other 
substrates from capillaries to mitochondria, and the transfer of high energy 
phosphate compounds from mitochondria to myofibrils (Weibel, 1984; 
Kayar et al., 1986). In case of reduced oxygen supply, increase of the 
volume density of mitochondria in the fibre periphery would be beneficial to 
energy metabolism (Mainwood and Rakusan, 1982; Kayar and Banchero, 
1987). We investigated whether the minimal changes in mitochondrial 
distribution, i.e. subsarcolemmal aggregation, in skeletal muscle of some 
patients with myopathic complaints (Chung and Nonaka, 1988; Van Ekeren 
et al., 1991) may be caused by an impairment of the oxygen supply to 
mitochondria. 
Hardly anything is known from animal experimentation about the 
mobilization of skeletal muscle mitochondria during chronic hypoxia (Ban-
chero, 1987). Nevertheless the mitochondria experience reduced oxygen 
delivery at Fi02 = 0.08, in spite of respiratory and cardiovascular adaptive 
responses, as demonstrated Banchero et al. (1976), Piantadosi et al. (1986), 
and Katz and Sahlin (1987). A pilot study did not indicate alterations in 
mitochondrial content in sedentary animals under these conditions. To 
enhance the effect of hypoxia, we imposed a mild exercise regime in the 
normoxic animals and in 6 hypoxic animals. The remaining 6 hypoxic 
animals were kept sedentary to check the effect of training under hypoxic 
conditions. Mitochondrial proliferation is known to occur under different 
experimental conditions, e.g. cold exposure or endurance training, within a 
time span 21 to 42 days (Buser et al., 1982, Kayar et al, 1986). Thus we 
considered a period of 44 days adequate for our experiment. 
In our experiments chronic hypoxia resulted in decreased body weight, 
increased hematocrit, increased capillary density due to smaller fibre 
diameters, and changes in mitochondrial volume densities. 
Body weight at the end of the experiment was smaller in hypoxic 
animals than in normoxic ones. The smaller mean fibre diameter and the 
absence of atrophic fibres in the former indicate a retardation in growth 
rate, probably most pronounced at the beginning of hypoxia (Sillau and 
Banchero, 1977; Snyder et al., 1985), rather than a loss of body weight. 
Examination of the cardiovascular and respiratory system in the 
prematurely deceased animals revealed changes which could clearly be 
attributed to exposure to chronic hypoxia. We assume similar changes were 
present in surviving animals, which is indicated by the strong rise in 
hematocrit. These changes may further compromise oxygen delivery to the 
musculature. 
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The distribution and relative amounts of type I and type II fibres was 
unchanged in hyopoxic animals. SDH staining did not permit discrimination 
between type IIA and IIB fibres in normoxic animals (Green et al, 1984; 
Dubowitz, 1985) and, despite alterations in mitochondrial volume densities, 
the staining pattern of this oxidative enzyme was not appreciably changed in 
hypoxic animals. 
Capillary neoformation during hypoxia does not occur unless the 
oxygen delivery system is further challenged, e.g. by simultaneous exposure 
to cold (for review see Banchero, 1987). We did neither observe changes in 
the capillary network of the exercised hypoxic animals , nor in the sedentary 
ones. The situation of an unchanged capillary network supplying smaller 
muscle fibres would cause improved tissue oxygenation according to the 
Krogh model (for review see Kreuzer, 1982). 
An interesting observation was the difference in the response to hypoxia 
between soleus and e.d.l. muscle in both hypoxic groups. In the former 
mitochondrial volume density increased, whereas it decreased in the latter. 
The different reaction patterns may be explained by the different types of 
energy metabolism occurring in each muscle. In soleus muscle, which is 
mainly dependent on aerobic phosphorylation for energy production, the 
relative increase in mitochondrial content, which is proportional to respirato-
ry capacity (Weibel, 1984), enabled the fibres to maintain energy production 
at reduced tissue Po2 (Holloszy and Booth, 1976; Hochachka et al., 1983). 
E.d.l. muscle probably reinforced its glycolytic capacity (Howald et al., 
1990) and concomitantly lost part of its oxidative capacity. This basic 
difference was also expressed by the demonstration that myoglobin content 
increases in soleus but not in gastrocnemius muscle after hypoxia (Sillau et 
al., 1980). 
The effect of training on mitochondrial volume density appeared to be 
similar under hypoxic conditions as the effect that is known from normoxic 
conditions. Under normoxic conditions, training induces an increase in 
mitochondrial volume density both in oxidative and glycolytic fibres (Ho-
wald et al., 1985; vSchwerzmann et ai, 1989). We noted a tendency that 
mitochondrial volume density of both soleus and e.d.l. muscle was larger in 
trained than in untrained hypoxic animals. 
In conclusion, we found no subsarcolemmal aggregation of mitochon-
dria in rat soleus and e.d.l. muscle after chronic exposure to hypoxia. 
However, in soleus muscle the volume density of mitochondria increased, 
whereas it decreased in e.d.l. muscle. This difference may be due to the 
predominant presence of type I fibres in soleus, and of type II fibres in 
e.d.l. muscle. The mitochondrial population in soleus muscle was redistribu-
ted in favour of the intermyofibrillar mitochondria. 
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CHAPTER 7 
Concluding remarks 
Patients with clinical and histopathological indications of a disordered 
energy-generating capacity, but without signs of any disturbance in the 
intramitochondrial part of energy metabolism in skeletal muscle were 
investigated. These patients presented a problem in that they could not be 
ranged in a biochemical classification of mitochondrial myopathies, and 
pathogenetic mechanisms are obscure. In this chapter some concluding 
remarks about the consequences of the findings presented in Chapters 2, 3, 
and 4 regarding the pathogenetic mechanisms are briefly discussed. A 
discussion follows on the validity of the animal model with regard to the 
hypothesis of impaired oxygen delivery in the patients. The results of the 
animal experiments (Chapter 6) are considered in relation to the histopatho-
logical findings in the EIMOS patients. 
Clinical manifestations 
The classification of patients suffering from a mitochondrial myopathy 
is based on a triad of clinical, histopathological and biochemical features. 
The complete triad, however, is seldom encountered (Lombes et al., 1989). 
Clinical presentation is very diverse and is only occasionally related to 
particular histopathological hallmarks or enzyme deficiencies. Histopatho-
logical features are non-specific and may also be seen in non-mitochondrial 
diseases (for reviews see DiMauro et al., 1985; Morgan-Hughes, 1986; 
Stadhouders and Sengers, 1987). Biochemically identified deficiencies can 
be divided into defects in: substrate transport or utilization; Krebs cycle; 
oxidation-phosphorylation coupling; or the respiratory chain (DiMauro et 
al., 1987). All of these defects occur in association with clinically overt 
signs of impaired energy production, but they are non-specific for a particu-
lar clinical manifestation or for a particular histopathology. In many patients 
evidence for a primary biochemical defect cannot be demonstrated. More 
recent methods of investigation include the molecular biological approach. 
Mitochondrial DNA deletions were demonstrated in several patients (for a 
review see Holt et al., 1989). This method of investigation is not yet 
suitable for routine diagnostic procedures. 
The patients in this study have in common disabling fatigability, no 
evidence of disturbed mitochondrial function in vitro and an increase in the 
volume density of skeletal muscle mitochondria, particularly in the subsarco-
lemmal region. Other clinical and histopathological findings were diverse. 
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Patients with the Nijmegen syndrome 
These patients suffered from a syndrome consisting of congenital cata­
ract, mitochondrial myopathy of heart and skeletal muscle, and lactic 
acidosis. For the sake of brevity this is entitled "Nijmegen syndrome". It is 
registered under number 21235 on the McKusick register (1990). Although 
bilateral cataracts were present at birth in all the members of this group, the 
subsequent course of the disease permitted an obvious distinction between 
two groups. Patients with the fatal infantile form usually appear healthy 
shortly after birth, but within several hours to days their condition deteriora­
tes drastically and death, due to hypertrophic obstructive cardiomyopathy, 
occurs within the first weeks of life. Most patients suffering from the 
relatively benign form of the disease die in the second or third decade due 
to the same cause. The physical state of these patients is not dependent on 
cardiomyopathy, unless obstruction occurred, but on skeletal muscle functi­
on. This function was never so seriously disturbed that a life threatening 
situation occurred. 
There are several indications that oxygen deficiency might be involved 
in the pathogenesis of the syndrome (Chapter 5), but otherwise a pathogene­
tic role for mitochondrial and/or nuclear DNA mutations affecting the 
synthesis of mitochondrial enzymes is not yet excluded. Recently, deletions 
in mitochondrial DNA were demonstrated in patients with clinical and 
histopathological signs of mitochondrial myopathy, despite normal oxidation 
rates of skeletal muscle mitochondria in vitro (personal communication W. 
Ruitenbeek). The mode of inheritance of diseases due to mitochondrial DNA 
mutations is theoretically maternal, but it was shown that transmission of 
mutant mtDNA may also mimic other modes of inheritance (Zeviani et αι., 
1989). This may indicate an interaction between proteins of mutated nuclear 
genes and the integrity of mtDNA. In mitochondrial myopathies associated 
with deletions in mtDNA, the increase in the content of mitochondria may 
be due to a loss of proliferative control elements in mutant mtDNA which 
are present in wild-type DNA (Shoubridge et ai, 1990). The co-existence of 
two populations of mitochondria, i.e. wild-type and mutant, might also 
explain the apparent contradiction where no biochemical abnormality is seen 
in vitro in patients with clinical signs of impaired energy production. The 
wild-type population might produce normal amounts of ATP during exercise 
and also give normal results at in vitro investigation. However, concomitant 
stimulation of the defective population may cause pathologic lactate produc­
tion. The ensuing increase in lactate concentration and decrease in intracellu­
lar pH might have an inhibiting effect on force production (Godt et al., 
1986) and contribute to the development of fatigue. The finding that intrami­
tochondrial vesicles (Fig 3b, Chapter 3) occur predominantly in patients 
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with severe lactacidemia (personal communication AM Stadhouders) also 
suggests that intracellular accumulation of lactic acid is involved in the 
histopathogenesis. However, caution should be exercised because lactacide-
mia is not necessarily connected to an intracellular drop of pH (Radda et 
al, 1985). 
Summarizing, in the pathogenesis of the Nijmegen syndrome the roles 
of neither oxygen deficiency nor mutations in mitochondrial and/or nuclear 
DNA can be excluded. Investigation of the effect of impaired oxygen 
delivery in the perinatal period and molecular biological investigation of 
mitochondrial and nuclear DNA might provide insights into the pathogenesis 
of this syndrome. 
EIMOS patients 
In EIMOS patients the clinical picture is not uniform. Genetic aspects 
are not involved. The first signs of increased fatigability are noted either at 
birth or later. The course is not unfavorable. Involvement of the central 
nervous system should be considered since mild mental retardation frequent-
ly occurs, but this does not appear to be the cause of the increased fatigabi-
lity. It is noteworthy that lactic acidosis was absent in all our patients. 
A tendency was noted that poorer exercise tolerance correlates positive-
ly to higher volume densities of peripheral mitochondria. The significance of 
an increased volume density of mitochondria as a means by which skeletal 
muscle tissue combats fatigability is discussed in Chapter 5. It was hypothe-
sized that fatigability in our patients was caused by impaired oxygen 
delivery to the mitochondria, and that the increase in volume density of 
mitochondria represents an adaptive response of skeletal muscle tissue. The 
structure of the mitochondria, in particular of the inner membrane, was 
unchanged. Therefore the increase in volume density probably signifies an 
increase in the aerobic capacity of the cell (Weibel, 1984). Increased aerobic 
capacity allows accelerated removal of cytosolic ADP (Gollnick, 1983) and 
reduced formation of lactate from pyruvate. These adaptive mechanisms are 
also considered to be adjustments to decreased oxygen supply (Hochachka et 
al., 1982). Holloszy (1973) suggested that changes in ADP and/or ATP 
concentrations from their homeostatic levels will be only half as much in 
skeletal muscle that has twice the amount of mitochondria. To produce the 
same amount of ATP per unit volume of muscle, muscle with twice the 
mitochondrial density will needs only half the change in ADP and P, 
concentrations. The important metabolic consequences of the smaller 
disruption in the levels of these compounds will be lower substrate fluxes of 
creatine kinase, adenylate kinase, AMP deaminase, and glycolysis (Consta-
ble et al., 1987). These adaptive alterations in metabolic flux slow down the 
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increase in lactic acid formation and carbohydrate depletion, thus delaying 
the onset of fatigue (Shoubridge et al., 1985; Lai and Booth, 1990). 
Another important beneficial effect of an increased mitochondrial 
population is an increase in the oxygen extraction from capillaries due to a 
greater Po2 gradient from hemoglobin to mitochondria (Erney et al., 1991). 
If impaired delivery of oxygen were involved in EIMOS patients, then 
what pathological alteration might be the cause of this disturbance, provided 
that pulmonary gas exchange, cardiac output and the oxygen carrying 
capacity of blood is normal? Within muscle tissue, several microphysio-
logical parameters (Chapter 5) determining oxygen supply may be changed 
under pathological conditions. These factors include: 1. distribution/perfus-
ion ratio of the capillary meshwork; 2. perfusion of capillaries (e.g. mi-
croembolization, compression by edema); 3. diffusion across the capillary 
membrane, through the interstitial tissue and across the sarcolemma; and 4. 
diffusion within the sarcoplasm, facilitated by myoglobin. This may result in 
an imbalance between oxygen supply and oxygen consumption. 
Not all of these possibilities are equally probable in our patients. If the 
geometric heterogeneity of the capillary network were to increase, it is most 
likely that hypoxic and/or anoxic regions would occur within the tissue 
(Turek and Rakusan, 1981; Turek etal., 1991). The geometric heteroge-
neity could not be investigated by morphometric analysis due to the tortuosi-
ty of the capillaries in needle biopsy material. Occlusion of capillaries 
probably causes anoxic regions and accompanying histopathologic changes, 
e.g. swelling of endothelium, swelling and disruption of mitochondria. This 
was not seen in the biopsy material of our patients. Although the morpholo-
gy of capillary membrane, sarcolemma and interstitial tissue appeared 
normal on microscopic examination, physicochemical alterations in these 
components might still cause extra resistance to oxygen diffusion. Alterati-
ons in the content or structure of myoglobin, which are also not detectable 
by routine microscopic examination, may interfere with its function. It is 
generally accepted that myoglobin facilitates oxygen diffusion within the 
sarcoplasm (De Koning et al., 1981; Buerk et al., 1989), although other 
mechanisms may also be involved in the decreased oxidation rate after 
inactivation of myoglobin (Doeller and Wittenberg, 1991). 
Experimental studies 
Experimental manipulation of oxygen supply or diffusion to mito-
chondria under in vivo conditions is problematic. The alteration of factors 
involved in oxygen transport, e.g. capillary endothelium or myoglobin, 
without influencing other factors is practicably impossible. Ligation of the 
femoral artery is a commonly used model for the study of tissue alterations 
due to hypoxia. It simulates the situation which exists in patients with 
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peripheral arterial occlusive disease. The observed tissue alterations are 
assumed to be due to hypoxia (Angersbach et al., 1987; Bylund-Fellenius et 
al., 1981; Erney et al., 1991). However, ligation of the femoral artery 
decreases not only oxygen supply, but also supply of other blood-borne 
substrates as well as the removal of the waste products of metabolism. The 
assumption in this study is that hypoxic hypoxia, i.e. a lowering of the 
oxygen fraction in inspired air, is a more suitable model of tissue hypoxia 
than arterial ligation. In order to determine the degree of hypoxic hypoxia 
which leads to a diminished reaction rate of cytochrome oxidase, despite 
respiratory and cardiovascular adaptations, the work of Piantadosi et al. 
(1986) was used. These authors noted an increased content of reduced 
cytochrome oxidase in cat skeletal muscle at an Fi02 of 0.09 or less, using 
near infra-red spectrophotometry (NIRS). Recent data of Colier et al. 
(1992), not available at the time our experiments were planned, indicated 
that NIRS determination of the redox state of cytochrome oxidase may be 
mimicked by signals from hemoglobin. Nevertheless, other investigations 
support the view that at an Fi02 of 0.08, the reaction rate of cytochrome 
oxidase is lowered due to limited availability of oxygen (Ranchero et al., 
1976), especially when mild exercise is performed (Katz and Sahlin, 1987). 
It should be noted however, that this does not necessarily mean that intracel-
lular Po2 is less that the in vitro Km of cytochrome oxidase. Harrison et al. 
(1990) noted a decrease in oxygen consumption in dog skeletal muscle 
during hypoxic hypoxia despite the absence of tissue Po2 values below 2.5 
mmHg. The "apparent" Km of cytochrome oxidase in tissue may be consi-
derably higher than the "true" Km of the isolated enzyme (Kreuzer et al., 
1991). It might be expected that new methods for the measurement of 
oxygen concentrations in tissues, e.g. electron paramagnetic resonance 
(Swartz et al., 1992) and the combination of measurement of oxygen in 
microcirculation by Pd-porphyrine phosphorescence with oxygen in tissue by 
NADH fluorescence (Ince et al., 1992), will provide more insight into the 
effects of oxygen supply manipulations to cellular respiration. 
Assuming that, in our animal model, the muscle fibres are stimulated to 
develop adaptive responses due to a limited availability of oxygen, then the 
question arises which of the above-mentioned hypothetical situations of 
impaired oxygen delivery in the EIMOS patients is most comparable to the 
experimental method. If mitochondrial content and distribution is related to 
intracellular Po2, as suggested by Kayar and Banchero (1987) and Weibel 
(1984), then the effect on mitochondrial distribution of hypoxic hypoxia may 
be different from, for example, the effect of myglobinopathy. In hypoxic 
hypoxia, saturation of hemoglobin and capillary Po2 are decreased. This 
theoretically means that the Po, profile is lower than normal along the fibre 
radius and that anoxic regions might exist in the deeper parts of the muscle 
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fibres towards the end of the capillary. In contrast, in myoglobinopathy, the 
Po2 profile is steepened. This means that the fibre periphery might have a 
higher Po2 and the deeper parts of the fibre a lower Po2 than normal. 
Alterations in the distribution/perfusion ratio also results in a different Po2 
profile than hypoxic hypoxia (Turek et al., 1991). With regard to the effect 
on Po2 profiles, hypoxic hypoxia would probably be most comparable to 
conditions of an increased diffusion barrier between hemoglobin and the 
sarcolemma, including the sarcolemma itself. 
The different effects of the various hypothetical oxygen delivery 
disturbances on Po2 profiles should be taken into account when discussing 
the results of the experimental studies. In addition, it is unlikely that Po2 is 
the only determining factor of mitochondrial content and distribution. 
Decreased ATP and phosphocreatine production as a consequence of an 
oxygen delivery impairment may also be involved. Nevertheless, it does 
appear justified to simulate a situation of impaired oxygen delivery to 
mitochondria, as hypothesized in the patients, by hypoxic hypoxia. 
Results of animal experimentation and investigation of EIMOS patients 
The results of the animal model do not provide definite proof of all 
observed changes in mitochondrial population due to hypoxic hypoxia. This 
is at least partly due to the low numbers of surviving animals. Due to 
practical limitations, the number of animals investigated could not be 
increased. Some interesting tendencies did, however, appear. Under conditi-
ons of hypoxic hypoxia the volume density of mitochondria appears to 
increase in muscle which is mainly composed of oxidative fibres (soleus 
muscle), but it appears to decrease in muscle which is mainly composed of 
glycolytic and mixed oxidative-glycolitic fibres (e.d.l. muscle). Additionally, 
a change in distribution occurs in favor of the intermyofibrillar mitochondria 
in soleus muscle. These differences between the two types of muscle may 
reflect a difference in the reaction to impaired oxygen delivery between 
oxidative and glycolytic fibres. Thus, mitochondrial proliferation and 
distribution changes might occur in oxidative fibres probably as an adaptive 
response to impaired oxygen delivery, caused by chronic hypoxic hypoxia. 
Human quadriceps muscle is composed of oxidative, mixed oxidative-
glycolytic and glycolytic fibres in about equal proportions (Dubowitz, 1985). 
The results of morphometric investigation present an overall value for this 
population and do not distinguish between possible differences in volume 
densities in the various fibre types. Thus, the increase in volume density of 
subsarcolemmal mitochondria may be equally present in all fibres or it may 
be restricted to one or more fibre types. 
It may be concluded that the increase of the volume density of subsar-
colemmal mitochondria observed in the EIMOS patients, regardless of its 
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possible restriction to a certain fibre type, does not occur in rat skeletal 
muscle under conditions of chronic hypoxic hypoxia. However, the results 
of morphometric analysis of soleus muscle indicate that mitochondrial 
proliferation might be involved in the adaptive response to chronic hypoxic 
hypoxia. Due to unawareness of the effects of the various kinds of oxygen 
delivery impairments on mitochondrial distribution, a pathogenetic role for 
impaired oxygen delivery in EIMOS patients cannot be excluded. It should 
be noted that both clustering of mitochondria near capillaries (Mainwood 
and Rakusan, 1982) and the opposite, i.e. declustering and homogenization 
of mitochondrial distribution (Jones et al., 1990) were proposed as benefici­
al mechanisms against impaired oxygen delivery. 
Further research is needed to confirm or exclude the possibility that 
impaired oxygen delivery is a pathogenetic factor in these patients. Particu­
larly the role of myoglobin should be investigated. Recent immunohistoche-
mical studies indicate that myoglobin has a particular distribution pattern in 
muscle fibres; i.e. myoglobin is predominantly associated with the I-zones 
as well as the outer membranes of the mitochondria. It was demonstrated 
that the myoglobin distribution pattern may be disturbed in a variety of 
neuromuscular disorders (Kawai et al., 1991). Measurement of intermediates 
of cellular metabolism and Po2 by new techniques (Ince et al., 1992; Swartz 
et ai, 1992) may provide further insight into the mechanisms underlying the 
disabling fatigability of our patients. 
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CHAPTER 8 
Summary 
In this thesis children with exercise intolerance and alterations of the 
structure and/or quantity of skeletal muscle mitochondria are presented. The 
complaints are of uncomprehended origin. Particularly no indications were 
observed for a disturbance in mitochondrial function under in vitro conditi-
ons. 
After a general introduction to the subject of mitochondrial myopathies 
(Chapter 1), the investigation of patients is described in Section I (Chapters 
2, 3, and 4). In Section II (Chapters 5 and 6) a hypothesis is considered that 
impaired oxygen delivery to mitochondria might be a pathogenetic factor in 
the patients. The experimental approach to test the hypothesis with regard to 
part of the patients is described. In Chapter 7 some concluding remarks 
concerning the pathogenesis are discussed, in particular with regard to the 
results of animal experimentation. Chapter 8 is the summary of this thesis. 
In Chapter 1 several features of mitochondrial myopathies (MM's) are 
considered. Clinical presentation may be confined to signs of skeletal muscle 
dysfunction; in particular exercise intolerance is a frequently occurring 
symptom. In other patients indications of a more widespread multisystem 
disease are observed. Histopathological and biochemical findings are non-
specific for clinical presentation. With regard to the etiology primary and 
secondary MM's can be distinguished, i.e. with and without a biochemically 
detectable enzyme deficiency in mitochondrial metabolism, respectively. 
The investigated patients can be separated into two categories. The first 
group suffered from the hereditary syndrome of congenital cataract, mito-
chondrial myopathy of skeletal muscle, hypertrophic cardiomyopathy and 
lactic acidosis, referred to as Nijmegen syndrome. The objectives were to 
determine the course of the disease and the existence of prognostic factors. 
The second group, referred to as EIMOS patients, presented with 
disabling fatigability and exercise intolerance in combination with miscella-
neous other symptoms. The relationship between clinical features, course, 
laboratory data and histopathological alterations was investigated. 
In Chapter 2 the results of investigation of Nijmegen syndrome patients 
are presented. The syndrome may take two distinctive courses: the fatal 
neonatal form, with death occurring in the first weeks after birth, or the 
relatively benign form, with death occuring in the second or third decade. 
Left ventricle outflow obstruction was the common cause of death. If it 
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developed soon after birth, this indicated the fatal neonatal form. Other 
clinical or histopathological criteria could not discriminate between the two 
forms. The two forms of the syndrome did not occur simultaneously in one 
family. Morphometric analysis of skeletal muscle tissue revealed increased 
volume density of subsarcolemmal mitochondria in all patients examined, 
and of intermyofibrillar mitochondria in the older patients. The structure of 
the mitochondria was predominantly severely disturbed. 
In Chapter 3 the results of histopathological and morphometric studies 
of heart and skeletal muscle in an infant with the fatal neonatal form are 
presented. Histopathological findings in heart muscle justified the use of the 
term mitochondrial cardiomyopathy. Enlargement of cardiomyocytes, partly 
caused by mitochondrial proliferation, contributed to cardiac hypertrophy. 
In Chapter 4 the results of investigation of EIMOS patients are presen-
ted. A clinical entity based on correlation of the incidence of symtoms and 
signs was not established. Morphometric investigation of skeletal muscle 
tissue revealed an increase of the volume density of peripheral mitochondria. 
The increase was statistically significant in 10 patients with regard to a 
control group. Patients with a statistically significant increase tended to 
exhibit lower exercise tolerance and slightly less favourable course than the 
others. 
In Chapter 5 the increase in the volume density of mitochondria, 
observed in the patients, is considered in relation to the clinical signs of 
exercise intolerance and increased fatigability. Under physiological conditi-
ons, an increase in mitochondrial volume density is a mechanism to combat 
fatigability. The possibility that impaired delivery of oxygen to mitochondria 
is a pathogenetic factor in the patients is discussed. With regard to Nijmegen 
syndrome patients this option was not further investigated due to practical 
limitations. With regard to EIMOS patients, an animal model is presented, 
intended to investigate whether impaired oxygen delivery to mitochondria 
causes an increase in the volume density of peripheral mitochondria. The 
impairment was assumed to be located within skeletal muscle tissue. The 
transport of oxygen from blood to mitochondria is briefly reviewed. 
Chapter 6 describes the animal model. Rats were exposed to hypoxic 
hypoxia (8% oxygen in inspired gas mixture; normal 21%) for 44 or 45 
days. Soleus muscle, predominantly composed of oxidative fibres, and 
extensor digitorum longus (e.d.l.) muscle, predominantly composed of 
glycolytic and mixed oxidative-glycolytic fibres were investigated. Capillary 
density was increased in both muscles due to smaller mean fibre diameters 
in hypoxic animals. In soleus muscle, mitochondrial volume density was 
increased and redistributed in favour of the intermyofibrillar mitochondria. 
In e.d.l. muscle mitochondrial volume density was decreased. 
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Chapter 7 presents some concluding remarks with regard to the patho-
genetic mechanisms which may be involved in the patients. In the Nijmegen 
syndrome a pathogenetic role for mitochondrial and/or nuclear DNA 
mutations is not yet excluded. 
With regard to the EIMOS patients the pathological alterations that 
might cause an impaired oxygen delivery are discussed. These alterations 
probably have different effects on Po2 (partial oxygen pressure) profiles in 
skeletal muscle tissue than hypoxic hypoxia. This must be taken into account 
when discussing the results of animals experimentation. 
The increase in the volume density of subsarcolemmal mitochondria, 
observed in EIMOS patients, was not noted in rat skeletal muscle after 
exposure to chronic hypoxic hypoxia. However, due to unawareness of the 
effects of the various kinds of oxygen delivery impairments on cellular 
distribution of mitochondria, a pathogenetic role for oxygen deficiency in 
EIMOS patients cannot be excluded. 
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HOOFDSTUK 8 
Samenvatting 
In dit proefschrift worden kinderen beschreven met inspanningsintole-
rantie en veranderingen in de structuur en/of de hoeveelheid van de mito-
chondriën in de skeletspier. De oorzaak van de klachten is onbekend. In het 
bijzonder werden er geen aanwijzingen gevonden, dat de funktie van de 
mitochondriën onder in vitro condities gestoord is. 
Na een algemene inleiding in het onderwerp mitochondriële myopathie-
en (hoofdstuk 1), wordt in Sectie I (hoofdstuk 2, 3 en 4) het onderzoek van 
de patiënten beschreven. In Sectie II (hoofdstuk 5 en 6) wordt de hypothese 
beschreven, dat een gestoord aanbod van zuurstof aan de mitochondriën een 
pathogenetische factor bij de patiënten zou kunnen zijn. De experimentele 
benadering van deze hypothese wordt beschreven. In hoofdstuk 7 worden 
tenslotte nog enkele pathogenetische overwegingen besproken, in het 
bijzonder met betrekking tot de resultaten van de experimentele benadering. 
Hoofdstuk 8 is de samenvatting van het proefschrift. 
In hoofdstuk 1 worden verschillende aspecten van mitochondriële 
myopathieën (MM's) besproken. Het klinische beeld kan beperkt zijn tot 
verschijnselen van skeletspier dysfunctie; inspannings intolerantie is hierbij 
een veel voorkomend symptoom. Bij andere patiënten worden aanwijzingen 
voor een uitgebreidere multisysteem aandoening gevonden. Histopathologi-
sche en biochemische bevindingen zijn niet specifiek voor de klinische 
verschijnselen. Wat betreft de ctiologie kunnen primaire en secundaire 
MM's onderscheiden worden, respectievelijk met en zonder biochemisch 
aantoonbare enzymdeficiencies in het mitochondriële metabolisme. 
De bestudeerde patiënten kunnen in twee categorieën ingedeeld worden. 
De eerste groep leed aan het erfelijke syndroom van congenitaal cataract, 
mitochondriële myopathie van de skeletspier, hypertrofische cardiomyopathie 
en lactaat acidóse. Dit wordt het Nijmegen syndroom genoemd. Het doel 
van het onderzoek van deze patiënten was het vaststellen van het verloop 
van de ziekte en van het bestaan van prognostische factoren. 
De tweede groep, de zogenaamde EIMOS patiënten, presenteerde zich 
met invaliderende vermoeibaarheid en inspanningintolerantie, in combinatie 
met verschuilende andere symptomen. De relatie tussen klinische verschijn-
selen, verloop, laboratorium bevindingen en histopathologische veranderin-
gen werd onderzocht. 
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Hoofdstuk 2 beschrijft de resultaten van het onderzoek aan de Nijmegen 
syndroom patiënten. Het verloop van het syndroom liet twee verschillende 
varianten zien: de fatale neonatale vorm, waarbij de patiënten binnen enkele 
weken na de geboorte overlijden, en de relatief goedaardige vorm, waarbij 
het overlijden plaatsvindt in het tweede of derde decennium. De doodsoor-
zaak was steeds een uitstroombelemmering van de linker ventrikel. Als deze 
zich kort na de geboorte voordeed, was er sprake van de fatale neonatale 
vorm. Andere klinische of histopathologische criteria maakten een onder-
scheid tussen de twee varianten niet mogelijk. De twee varianten kwamen 
nooit tegelijk binnen één familie voor. Morfometrisch onderzoek van het 
skeletspierweefsel toonde een toename van de volume dichtheid subsarco-
lemmale mitochondriën bij alle onderzochte patiënten aan, en van de 
intermyofibrillaire mitochondriën bij de oudere patiënten. De structuur van 
de mitochondriën was overwegend ernstig verstoord. 
In hoofdstuk 3 worden de resultaten van histopathologisch en morfome-
trisch onderzoek van hart en skeletspier van een kind met de fatale neonatale 
vorm beschreven. De histopathologische bevindingen in de hartspier recht-
vaardigen het gebruik van de term mitochondriële cardiomyopathie. Vergro-
ting van de hartspiercellen, gedeeltelijk veroorzaakt door proliferatie van 
mitochondriën, droeg bij aan de hypertrofie van het hart. 
In hoofdstuk 4 worden de resultaten van het onderzoek van de EIMOS 
patiënten beschreven. Een klinische entiteit, gebaseerd op een correlatie in 
het voorkomen van symptomen en onderzoeksbevindingen werd niet vastge-
steld. Morfometrisch onderzoek van skeletspierweefsel toonde een toename 
van de volume dichtheid van perifere mitochondriën. Deze toename was 
statistisch significant t.o.v. een controlegroep bij 10 patiënten. Patiënten met 
een statistisch significant toegenomen volume dichtheid neigden tot een 
lagere inspannings tolerantie en een minder gunstig verloop dan de anderen. 
In hoofdstuk 5 wordt de toename in de volume dichtheid mitochondri-
ën, die bij de patiënten gevonden werd, beschouwd in verband met de 
klinische verschijnselen van inspanningsintolerantie en toegenomen vermoei-
baarheid. Onder fysiologische omstandigheden is een toename in de volume 
dichtheid mitochondriën een mechanisme om vermoeibaarheid te bestrijden. 
De mogelijkheid dat een gestoord zuurstofaanbod een pathogenetische factor 
is bij de patiënten wordt besproken. Met betrekking tot de Nijmegen 
syndroom patiënten werd deze mogelijkheid door praktische beperkingen 
niet verder onderzocht. 
Met betrekking tot de EIMOS patiënten wordt een diermodel gepresen-
teerd, dat bedoeld is om te onderzoeken of een gestoord zuurstofaanbod aan 
mitochondriën leidt tot een toename van de volume dichtheid perifere mito-
chondriën. De stoornis in het zuurstofaanbod wordt verondersteld in de 
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skeletspier gelocaliseerd te zijn. De zuurstof overdracht van bloed naar 
mitochondriën wordt besproken. 
Hoofdstuk 6 beschrijft het diermodel. Ratten werden blootgesteld aan 
hypoxische hypoxie (8% zuurstof in het ingeademde gasmengsel; normaal 
21%). De musculus soleus, voornamelijk bestaande uit oxidatieve vezels en 
de musculus extensor digitorum longus, voornamelijk bestaande uit glycolyti-
sche en gemengd oxidatief-glycolytische vezels, werden onderzocht. De 
capillair dichtheid was toegenomen in beide spieren door een kleinere 
gemiddelde vezeldiameter in hypoxische dieren. In de musculus soleus was 
de volume dichtheid mitochondriën toegenomen en geredistribueerd ten 
voordele van de intermyofibrillaire mitochondriën. In de musculus extensor 
digitorum longus was de volume dichtheid mitochondriën afgenomen. 
In hoofdstuk 7 worden enkele slotopmerkingen gemaakt ten aanzien van 
de pathogenetische mechanismen, waarvan bij de patiënten sprake zou 
kunnen zijn. Bij de Nijmegen syndroom patiënten is een pathogenetische rol 
voor mutaties van het mitochondriële en/of nucleaire DNA niet uitgesloten. 
Met betrekking tot de EIMOS patiënten worden de pathologische 
veranderingen besproken, die een gestoord zuurstofaanbod zouden kunnen 
veroorzaken. Deze veranderingen hebben waarschijnlijk een ander effect op 
de Po2 (partiële zuurstofdruk) profielen in het skeletspierweefsel dan hypoxi-
sche hypoxie. Hiermee moet rekening gehouden worden bij het bespreken 
van de resultaten van het dieronderzoek. 
De toename van de volume dichtheid perifere mitochondriën, die in 
skeletspierweefsel van patiënten werd gezien, werd niet gevonden in skelet-
spier van ratten, die blootgesteld waren aan chronische hypoxische hypoxie. 
Omdat de effecten van de verschillende mechanismen die tot een gestoord 
zuurstofaanbod kunnen leiden, op de verdeling van de mitochondriën niet 
bekend zijn, kan echter een pathogenetische rol voor zuurstof deficiëntie bij 
de EIMOS patiënten niet uitgesloten worden. 
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